ESGAR
2022
May 31 – June 3
Annual Meeting and Postgraduate Course

N
O
B
S
I
L
L
A
G
U
T
POR

FINAL PROGRAMME

European Society of Gastrointestinal and Abdominal Radiology | www.esgar.org

ESGAR 2022 FINAL PROGRAMME
Important Addresses / CME / Contributing Societies / Support

2

Committees

3

Information from A – Z

4

Abstract Reviewing Panel / e-Poster Jury11

Welcome Addresses

12

Honorary Fellow

14Gold Medal

15

Programme

16

Tuesday, May 31

19

Wednesday, June 1

21

Thursday, June 2

29

Friday, June 3

37

Poster Presentations – Educational

45

Poster Presentations – Scientific52

Corporate Members

57

Industry Sponsored Symposia

59

Exhibitors and Sponsors

72

Floorplan Exhibition Area

73

Floorplan Lecture Rooms

74© European Society of Gastrointestinal and Abdominal Radiology
Date of publication: May 2022
ESGAR accepts no responsibility for errors or misprints.

ESSESIMPORTANT ADDRESSESEXHIBITION
MANAGEMENTVENUE
ORGANISING
SECRETARIAT
EXHIBITION
MANAGEMENT
EMENT
CONFERENCEVENUE CONFERENCECONFERENCE VENUE

MAW
Central
ESGAR
Office CenterRoma
Convention
Medizinische
AusstellungsundCloud“
Esslinggasse
2/3d
La Nuvola – ”The
Werbegesellschaft
AT –Viale
1010
ViennaAsia
40
International
Exhibitions
Advertising
Phone:+43 1&Rome
535
89 27
ertising
IT – 00144
Freyung 6/3
Fax:+43 1 535 89 27 15
AT – 1010E-Mail:
Vienna office@esgar.org
Phone: +43 1 536 63 73
Fax:+43
1 535 60 16
www.esgar.org
E-Mail: maw@media.co.atCentro de Congressos de Lisboa (CCL)
Praça das Indústrias
PT – 1300-307 Lisbon

www.media.co.atRoma Convention
CenterMAW
La NuvolaMedizinische– ”The Cloud“Ausstellungs- undViale Asia Werbegesellschaft
40
IT – 00144International
Rome
Exhibitions & Advertising
Freyung 6/3
AT – 1010 Vienna
Phone: +43 1 536 63 73
Fax:+43 1 535 60 16
E-Mail: maw@media.co.atwww.lisbonvenues.pt/
centro-decongressos-de-lisboa/

www.media.co.at

CME

th European
tinal“ESGAR
and Abdominal
Radiology”(or)Society“ESGAR2019– 30th Annual
Meetingand Postgraduate
TheofPostgraduate
GastrointestinalandAbdominal
Radiology” (or) “ESGAR 2022 – 33rd ANNUAL MEETING AND
or)2019“ESGAR– 30
Annual Meetingandditation
Councilfor
Continuing
Medical
Education(EACCME)to provideAccreditation
the followingCouncil
CME for Continuing Medical Education (EACCME) to provide
POSTGRADUATE
is accreditedby the European
edical Education(EACCME)
toCOURSE”
provide thefollowingCME
snion
an institutionoftheEuropean
Union
of
MedicalSpecialists(UEMS),
www.uems.net.
the following
CME
activity
for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS),of Medical
Specialists(UEMS),
www.uems.net.

www.uems.net.
eCourse,Rome,
Italy,been
05/06/2019– 08/06/2019
has been accredited by the European
9 – 08/06/2019 has
accreditedby the European®
rd®
Education(EACCME) with Meeting25 s).
European
CME credits(ECMECs). Each2022,
medialspecialist
The
33 Annual
andmedial
Postgraduate
Course ®ESGAR
Lisbon,Portugal, 31/05/2022 – 03/06/2022 has been accredited byuropeanCME
credits(ECMEC
Each
specialist®
he/sheactually
spent
in
the
educational
activity.
theEuropeanAccreditation
Councilfor
Continuing
Medical
Education(EACCME) with 26 European CME credits (ECMEC®s). Eachcational activity.
medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

CIETIESCONTRIBUTING SOCIETIESMEDIA PARTNER
DIA PARTNER

2

SUPPORTCOMMITTEESESGAR EXECUTIVE COMMITTEEPRESIDENT
Andrea Laghi, Rome/ITPRESIDENT-ELECT
Marc Zins, Paris/FR
VICE PRESIDENT
Jaap Stoker, Amsterdam/NL
SECRETARY/TREASURER
Valerie Vilgrain, Clichy/FR
EDUCATION COMMITTEE CHAIR
Christoph J. Zech, Basel/CH

MEMBERSHIP AND COMMUNICATIONCOMMITTEE CHAIR
Giuseppe Brancatelli, Palermo/IT

MEETING PRESIDENT 2024
Lennart Blomqvist, Stockholm/SE

WORKSHOP COMMITTEE CHAIR
Maria Antonietta Bali, Brussels/BE

MEMBERS AT LARGE
Sofia Gourtsoyianni, Athens/GR
Musturay Karçaaltincaba, Ankara/TR
Nikolaos Kartalis, Stockholm/SE
Maija Radzina, Riga/LV
Damian Tolan, Leeds/UK

MEETING PRESIDENT 2022
Luis Curvo-Semedo, Coimbra/PT

ESGAR EXECUTIVE DIRECTOR
Brigitte Lindlbauer, Vienna/AT

RESEARCH COMMITTEE CHAIR
Stuart A. Taylor, London/UK

MEETING PRESIDENT 2023
Asunción Torregrosa Andrés, Valencia/ES

ESGAR 2022 MEETINGPRESIDENTESGAR 2022 PROGRAMMECOMMITTEEESGAR 2022 LOCALORGANISING COMMITTEE

Luís Curvo-Semedo
Faculty of Medicine, University of Coimbra
Department of Medical Imaging
Coimbra University Hospitals
CIBIT – Coimbra Institute for Biomedical
Imaging and Translational Research
Coimbra, Portugal

CHAIRMAN
Jaap Stoker, Amsterdam/NL

Jorge Brito, Faro/PT
Filipe Caseiro Alves, Coimbra/PT
Luísa Costa Andrade, Lisbon/PT
Manuela França, Porto/PT
Luís Guimarães, Porto/PT
António J. Madureira, Porto/PT
Celso Matos, Lisbon/PT
Miguel Ramalho, Almada/PT
Daniel Ramos Andrade, Coimbra/PTInês Santiago, Lisbon/PT
José Traila Campos, Viana do Castelo/PT
José Venâncio, Lisbon/PT

MEMBERSMaria Antonietta Bali, Brussels/BE
Lennart Blomqvist, Stockholm/SE
Giuseppe Brancatelli, Palermo/IT
Luis Curvo-Semedo, Coimbra/PT
Sofia Gourtsoyianni, Athens/GR
Musturay Karçaaltincaba, Ankara/TR
Nikolaos Kartalis, Stockholm/SE
Andrea Laghi, Rome/IT
Maija Radzina, Riga/LV
Stuart A. Taylor, London/UK
Damian Tolan, Leeds/UK
Asunción Torregrosa Andrés, Valencia/ES
Valerie Vilgrain, Clichy/FR
Christoph J. Zech, Basel/CH
Marc Zins, Paris/FR

3

INFORMATION FROM A – Z
ABBREVIATIONS
The following abbreviations are used in the programme:

CLINICAL FILES
Thursday, June 2 in Auditorium I (17:00 – 18:00)

ES
ET
HL
IGT
LS
PG
PS
RT
SOE
SS
SY
TC
USV

An experienced moderator will present four themed andchallenging multimodality cases to a radiology panel. Each casewill be chosen to illustrate various diagnostic and therapeutic
options available for the clinical management of the patient. Theinterpretation session will be live, as the panellists will not see thecases before the session. The panellists will describe the imaging
findings. The moderator will guide the panellists with questions
regarding differentials and patient management. The aim of thissession is to stress the central role of clinical radiology in today’s
patient management and to show how experts deal with cases inreal life.

Editorial Session
ESGAR Tutorial
Honorary Lecture
Image Guided Therapy
Lecture Session
Postgraduate Course
Plenary Session
Research Tutorial
School of ESGAR
Scientific Session
Industry Symposium
Tricky Cases
Ultrasound Village

BADGES
It is obligatory for all participants to wear their name badge visibly
throughout the meeting as it is the entrance ticket to all sessions
and the exhibition. The name badge is not transferable. In case ofbadge loss, please contact the registration desk (Level 1). ESGAR
reserves the right to check your identification. You may be asked
at any time to present adequate proof of identity by showing yourpassport, driver’s licence, national or military identification or
student ID, all with photograph and signature.

BOOK OF ABSTRACTSThe ESGAR 2022 Book of Abstracts includes submitted andaccepted oral presentations and is only available online. It canbe viewed and downloaded via the ESGAR 2022 online Portal.

CASES OF THE DAY
Scientific Coordinator: C. Reiner, Zurich/CH
Different cases will be displayed each day from Tuesday, May
31 to Friday, June 3, giving registrants the opportunity to takepart in the quiz and check the results on the following day.
The participant who solves the most cases correctly will beannounced in the ESGAR Newsletter. The cases are accessible
via the computer terminals located in the Electronic Poster
Exhibition (Exhibition Area) as well as online.

4

CLOAKROOM
The coat check service is located on the right-hand side in the
Entrance Level Foyer.

CME ACCREDITATION & EVALUATIONESGAR uses a digital CME acquisition system in order to provide
more flexibility to delegates in regard to evaluating sessions andobtaining CME credits.
CME acquisition & Evaluation is possible via•	the ESGAR 2022 online Platform• the Evaluation Terminals (in the Exhibition Area)
CME credits will only be awarded if•	You have attended accredited sessions onsite or online infull length•	You have fully completed the electronic questionnaire foreach session attended and for the overall meeting
Please note that the evaluation of sessions is only possible fromMay 31 – September 3, 2022. Confirmation of attendance andrecord of attendance cannot be claimed at a later date as laterequests cannot be processed.

Guidance
Confirmation of attendance and record of attendance for CME
provider may be obtained as follows:
Scientific / Educational Sessions
1. Participate in the session of your interest
2. Log into the ESGAR 2022 online platform
3. Add the sessions you attended and wish to evaluate to yourcredit cart
4. Fill out the form completely after the session
5. Fill out the form for the overall meeting
Please use the Evaluation Terminals or use your own device toevaluate the session(s) you visited.
Record of Attendance for CME Provider/ Confirmation of
Attendance
You can download and print the record of attendance for CME
provider and the confirmation of attendance from the ESGAR
2022 online platform.
This service will be available until September 3, 2022. The
printout of your record of attendance has to be submitted to therespective national accreditation society. Please note that therecord of attendance is issued only to the participant. It will not be
supplied to any accreditation agency or other organisation/healthauthority. Although participants may partially attend multiple
concurrent sessions, the total number of hours printed at the endof the list limits the credit to the equivalent of a single session
during that time slot.

COFFEE CASH BARS
Within the congress centre the main catering area can be foundin the Auditorium Foyer.
Opening hours:
Tuesday, May 31		
Wednesday, June 1
Thursday, June 2		
Friday, June 3		

08:00 – 17:00
08:00 – 17:00
08:00 – 17:00
08:00 – 16:00

Complimentary coffee will be available in the Exhibition Area atthe following times:
Tuesday, May 31		
Wednesday, June 1
Thursday, June 2		
Friday, June 3		

10:00 – 10:30 / 15:30 – 16:00
10:30 – 11:00 / 16:00 – 16:30
10:30 – 11:00 / 16:00 – 16:30
10:30 – 11:00 / 13:30 – 14:00

EDITORIAL SESSION
Wednesday, June 1 in Auditorium VIII (11:00 – 12:30)
This session aims at introducing the Editorial world. Chief
Editors of peer reviewed scientific journals will provide insights
into different types of educational papers and their level ofevidence. Different impact factors and manuscript review
handling processes will be explained. The session will conclude
with an interactive discussion among editors and researchleaders; attendees are encouraged to actively participate and ask
questions they always wanted to ask the editors.

5

INFORMATION FROM A – Z
ELECTRONIC POSTER EXHIBITION
Exhibition Area (Level 1)
All scientific and educational exhibits (posters) at ESGAR 2022
are displayed in electronic poster format. The poster systemallows registrants to submit their exhibits online, to view themin the conference centre and online on the ESGAR 2022 online
platform. The scientific and educational posters displayed at
ESGAR 2022 in the electronic poster exhibition will be included in
the permanent ESGAR Online Poster Database after the meeting.
A number of computer terminals are available for viewing thepresentations.
Please refer to pages 45 – 56 of this programme for a complete
listing of presented posters sorted by topic.
Opening hours:
Tuesday, May 31		
Wednesday, June 1
Thursday, June 2		
Friday, June 3		

07:30 – 18:00
07:30 – 18:00
07:30 – 18:00
07:30 – 14:00

Poster Presentation Prizes
The evaluation of the poster presentations was completed
in advance of the meeting by a jury and was based on
novelty, accuracy, educational value and design. The
winners are indicated as such in the electronic poster
system. The 11 best poster presentations will receive a
diploma which can be collected at the Scientific Office.
The following prizes are awarded: Magna Cum Laude, Cum
Laude and Certificates of Merit.

Furthermore, the Board of Achievement with pictures of all
poster prize winners is displayed online. There are also the“Recommended Posters”, which were not selected for an award
but are recommended by the jury for their interesting and valuable
scientific educational content. All posters are also displayed on
special electronic poster terminals located in the Exhibition Area.

EMERGENCY
The number 112 can be dialled to reach emergency services –medical, fire and police – from anywhere in Europe. The operator
redirects the call to the appropriate service. This Pan-European
emergency number can be called from any telephone (landline,
pay phone or mobile phone) and is free of charge.

6

ESGAR TOP 20
The best 20 abstracts, submitted by residents, who appear as thefirst author on the respective abstract and who actually present
their paper during the meeting, form the “ESGAR Top 20”. Authors
receive a diploma, which can be collected at the Scientific Office.
Furthermore, the Board of Achievement with pictures of allawarded presenters is displayed online.

ESGAR TUTORIALS
Throughout ESGAR 2022, different tutorials will be offered to theregistrants. Compared to a formal lecture, the smaller tutorial
environment is intended to facilitate more active discussion
between expert instructors and the audience, allowing registrants
to address their specific needs.

HONORARY LECTURESESGAR continues the traditional format of the Honorary Lecture
Sessions. Besides the ESGAR Honorary Lecture, one session
is organised in collaboration with the Society of Abdominal
Radiology (SAR).

IMAGE GUIDED THERAPY
An educational feature focusing on Interventional Radiology(IR) in the GI tract and Abdomen was first introduced during
the ESGAR 2009 Annual Meeting. Since then, it was expanded
at subsequent meetings in order to reflect the central
role interventional techniques play in the multidisciplinary
management of patients with gastrointestinal and abdominal
diseases. The daily IGT sessions will be led by experts in the field,
emphasising key practical issues, ranging from basic to advanced
knowledge and skills with a special focus on knowledge usefulfor abdominal radiologists working in diagnostic radiology.
As in all ESGAR formats, interactivity will be encouraged
between delegates and faculty in order to facilitate usefulpractical discussions. This includes case discussions led by themoderators, including all speakers. We believe that this particularformat will help to augment the various practical aspects andprocedural tips and tricks and encourage the audience to interact
with IR experts in this learning environment.

INDUSTRY SYMPOSIA
From Tuesday to Friday at lunchtime, symposia will be held in
collaboration with industrial companies and corporate partners.
The subjects of these symposia will include a variety of “hottopics” concerning the ongoing development in some major fieldsof abdominal diagnostic and interventional radiology.
Your name badge is your business card. ESGAR and its sponsors
are using a lead retrieval system during the congress. In practicethat means that when you present your badge for scanning at
an exhibition booth or for scanning when entering an industry
sponsored lunch symposium, the following personal data can be
retrieved: first name, last name, address details, email address.

INFORMATION DESKAt ESGAR 2022, we’re offering an information and traveldesk. Here you can get information about the city of Lisbon,
recommendations for shopping as well as restaurants and thebest places to have a drink.
Opening hours:
Tuesday, May 31		
Wednesday, June 1
Thursday, June 2		
Friday, June 3		

07:30 – 18:00
08:00 – 18:00
08:00 – 18:00
08:00 – 15:30

INTERNET ACCESSFree wireless LAN access is available throughout the congress
venue and all lecture rooms free of charge.

LANGUAGE
The entire meeting is held in English.

LECTURE HALLS
Auditorium I, Auditorium II, Auditorium III, Auditorium VI,
Auditorium VIII, Room 5A, Room 5C

LECTURE SESSIONSAll Lecture Sessions are dedicated to a special area of interest
with defined lecture objectives to ensure integration and avoid
overlap. Several sessions have a multidisciplinary approach or
are organised in collaboration with other societies such as theEuropean Society of Urogenital Radiology (ESUR).

LIABILITYESGAR is not liable for personal injury and loss of or damage
to private property. Participants should obtain the appropriate
travel insurance. The place of performance of any duties andobligations for both ESGAR and the participant’s sides shall be
Vienna, Austria. Any contractual relationship with ESGAR shall be
subject to Austrian law.

LOST AND FOUND
Lost and found articles may be picked up or handed in at theregistration desk.

MODERATORS DESK
Moderators are kindly asked to check in at the moderators’ deskin the ESGAR Scientific Office at least 30 minutes before thesession they are chairing, in order to pick up their documents.

NICK GOURTSOYIANNIS’ FOUNDATION COURSE I and II
Friday, June 3 in Auditorium I
Foundation Course 1 (14:00 – 15:00):
Radiologic-pathologic correlation: Pancreas
Foundation Course 2 (15:00 – 16:00):
Radiologic-pathologic correlation: GI tumours
This educational feature, named after Prof. N. Gourtsoyiannis, isa mini rad-path course designed to teach fundamental imaging
findings in specific abdominal conditions correlated with up-todate pathologic information. The specific topics to be discussed
in this year’s rad-path course are the pancreas (pancreatic cystic
tumours and non-adenocarcinoma pancreatic solid tumours)
and GI tumours (non-adenocarcinoma gastric cancer and nonepithelial bowel tumours).

7

INFORMATION FROM A – Z
ONE CASE – THREE LESSONS
Wednesday, June 1 in Auditorium I (16:45 – 18:00)
Returning by popular demand for a third year, we continue withthe format called “One case – three lessons”. Is reflection an
important part of your practice? In this session each panellist
explains a clinical case where they personally made a mistakeand then develop the three lessons that they learned from this.
The goal of this format is to learn how experts reflect on theirown errors to avoid making important mistakes in the diagnosis
of difficult cases in the future. A broad range of diseases,
modalities and clinical situations will be presented, and themoderators will bring together shared themes during discussion
amongst the experts. The session will be managed like a Jazz
session, entertaining and educating with improvisation, humour
and rhythm.

POSTGRADUATE COURSE
Tuesday, May 31 in Auditorium I
Bowel imaging in the spotlight: from diagnosis to patientmanagement
At ESGAR 2022, a Postgraduate Course entitled “Bowel imaging
in the spotlight: from diagnosis to patient management” isoffered on the first day of the meeting. In four sessions the
topics of Crohn’s disease, ischemic bowel disease, postoperative
GI tract and rectal cancer are addressed. Each session deals
with the respective imaging diagnosis and challenges and also
focuses on the appropriate multidisciplinary management ofpatients. A 45-minute case-based discussion at the end of each
Postgraduate Course session exemplifies the topic and enhances
the learning experience.
PREVIEW CENTRE

PHOTOGRAPHY
Please be aware that the Annual Meeting and Postgraduate
Course is an event where photography will occur. By
participating in the event you consent to your likeness being
used, without compensation, in any and all media. If you do notwish to be included in a photograph please let the respective
photographer know.

Speakers are reminded to check in no later than 90 minutes
before the beginning of their session. For ESGAR Tutorials
taking place in the early morning please check in the day before.
Only data projection will be provided for oral presentations.
Presentations must be prepared using PowerPoint for PC.
Speakers must deliver their presentation to the Preview Centre
on a USB memory stick (ZIP disks are not accepted). The sizeof one presentation should not exceed 500 MB. Presenters havethe opportunity to test their presentations directly in the Preview
Centre which is strongly recommended. Due to space and time
limits it is not possible to prepare and rehearse your complete
presentation.
Opening hours:
Tuesday, May 31 		
Wednesday, June 1
Thursday, June 2 		Friday, June 3 		

8

07:30 – 18:00
07:30 – 18:00
07:30 – 18:00
07:30 – 14:30

REGISTRATION
Opening hours:
Monday, May 30		Tuesday, May 31 		
Wednesday, June 1
Thursday, June 2 		Friday, June 3 		RESEARCH TUTORIALS
Wednesday, June 1 – Friday, June 3 (12:45 – 13:45)
15:00 – 18:00
07:30 – 19:30
07:30 – 18:30
07:30 – 18:00
07:30 – 15:30

Onsite Fees:ESGAR Faculty Member
ESGAR Member
Non Member
Resident* (ESGAR Member)
Resident* (Non Member)Radiographer/Technician/Nurse (Member)Radiographer/Technician/Nurse (Non Member)Medical student**Industry Delegate

Have you begun your academic career and want to know how toadvance to become a leader in research? It is much more thanpublishing papers, grant funding etc. In these research tutorials
major aspects of abdominal imaging research will be discussed
by leading ESGAR researchers.

€ 490.00€ 790.00€ 990.00€ 450.00€ 550.00€ 450.00€ 550.00€
90.00€ 1090.00* Residents and radiographers must provide a letter from their headof department confirming their status as a resident or radiographer toregister for this fee. The age limit for registrations as resident is 35 (incl.
the age of 35).
** Medical students under the age of 30 without academic title canregister for this fee. Please provide a student proof (student ID or letter ofuniversity).

The registration fee includes:• Admittance to all sessions (onsite or online), scientificexhibition (ESGAR Posters), technical exhibition•	Access to all on-demand content (recorded, previously live
streamed sessions, poster exhibition, case discussions)•	Final Programme (in print) and Book of abstracts(online version)• Confirmation of Attendance• Record of Attendance for CME Provider• On-demand content accessible until September 3, 2022
All prices are listed in Euro (€). The “ESGAR Member” registration
fee is only applicable for members in good standing – themembership fee for 2022 has to be settled. Onsite membership
applications cannot be accepted.

SCHOOL OF ESGAR
Scientific Coordinators: R. Cannella, Palermo/IT; K. De Paepe,
Cambridge/UK; C. Reiner, Zurich/CH
This is an educational pathway within the ESGAR Annual Meeting
which includes a selection of the most important topics ofabdominal radiology following the chapters of the European
Training Curriculum and the corresponding learning objectives.
This pathway will cover the most fundamental and important
clinical aspects of abdominal imaging and an in-depth discussionof a selection of important common and less common diseases.
The School of ESGAR will be open from Wednesday, June 1 to
Friday, June 3, 2022.

SCIENTIFIC SESSIONS
Wednesday, June 1 – Friday, June 3
Researchers will present original papers on new and original
aspects of abdominal imaging and intervention. Selected papers
will be gathered into sessions, each dealing with a homogenous
topic. Time for discussion between researchers and attendees
will be available after each presentation.

SMOKING
Smoking is not permitted inside the conference venue.

SOCIAL MEDIAThe official congress hashtag for Twitter and Facebook is#esgar2022.

Onsite Fees must be paid by credit card (VISA or MasterCard).

9

INFORMATION FROM A – Z
TECHNICAL EXHIBITION
Exhibition Area
For a complete list of exhibitors and a floorplan of the exhibitionarea, please refer to pages 72 – 73.
Opening hours:
Tuesday, May 31 		
Wednesday, June 1
Thursday, June 2		
Friday, June 3		

09:30 – 18:00
09:30 – 17:00
09:30 – 17:00
09:30 – 14:00

TRICKY CASES FROM MY DAY JOBCoordinators: M. Laniado, Dresden/DE; R. Cannella, Palermo/IT;
K. De Paepe, Cambridge/UK; C. Reiner, Zurich/CH
Wednesday, June 1 and Thursday, June 2, 12:45 – 13:30,
Auditorium II
This session format on Wednesday, June 1 and Thursday, June 2,
involves brief case presentation and interactive discussion ofchallenging cases from everyday clinical practice.

ULTRASOUND VILLAGE
Wednesday, June 1 – Friday, June 3, Room 5C
Scientific Coordinators: J.B.C.M. Puylaert, The Hague/NL;
M. Ramalho, Almada/PT
At ESGAR 2022, the modality of ultrasound will be one of thehighlighted topics. Throughout the meeting, sessions, tutorials
and key-note lectures will encompass basic technical aspects
as well as innovations in abdominal ultrasound, as contrast
enhanced ultrasound and new techniques such as elastography,
fusion imaging and 3D. However, there will also be ample
attention for the clinical triage-function of ultrasound as a primarytool, workhorse and starting point in any abdominal problem.

YOUNG ESGAR LOUNGE
Young ESGAR (YE) is a forum of enthusiastic young ESGAR
members to represent the interests of residents, young
radiologists and researchers within the ESGAR community.
The Young ESGAR lounge is located in Room 1.05 on Level 1,
next to the ESGAR Scientific Office.
Opening hours:
Tuesday, May 31
Wednesday, June 1
Thursday, June 2
Friday, June 3

10

10:00 – 10:30, 12:30 – 13:30 & 15:30 – 16:00
10:30 – 11:00, 13:30 – 14:30 & 16:00 – 16:30
10:30 – 11:00, 13:30 – 14:30 & 16:00 – 16:30
10:30 – 11:00

ABSTRACT REVIEWING PANEL / E-POSTER JURY
O. Akhan, Ankara/TR
T.V. Bartolotta, Palermo/IT
A. Ba-Ssalamah, Vienna/AT
N. Bastati-Huber, Vienna/AT
R.G.H. Beets-Tan, Amsterdam/NL
E. Biscaldi, Genoa/IT
A. Blachar, Tel Aviv/IL
L. Blomqvist, Stockholm/SE
I. Boulay Coletta, Paris/FR
G. Brancatelli, Palermo/IT
R. Cannella, Palermo/IT
F. Caseiro Alves, Coimbra/PT
K. Cortis, Msida/MT
L. Crocetti, Pisa/IT
L. Curvo-Semedo, Coimbra/PT
G. D’Assignies, La Roche-sur-Yon/FR
M. Dioguardi Burgio, Villejuif/FR
A. Dohan, Paris/FR
R.F. Dondelinger, Liège/BE
M. D’Onofrio, Verona/IT
H. Fenlon, Dublin/IE
A. Furlan, Pittsburgh, PA/US
Y. Gandon, Rennes/FR
V. Goh, London/UK
M. Gollub, New York, NY/US
S. Gourtsoyianni, Athens/GR
J.A. Guthrie, Leeds/UK
T. Helmberger, Munich/DE
F. Iafrate, Rome/IT

D. Ippolito, Monza/IT
S. Jackson, Plymouth/UK
M. Karçaaltincaba, Ankara/TR
A. Laghi, Rome/IT
D. Lambregts, Amsterdam/NL
M. Laniado, Dresden/DE
J.M. Lee, Seoul/KR
O. Lucidarme, Paris/FR
M. Maas, Amsterdam/NL
A.J. Madureira, Porto/PT
M. Maher, Cork/IE
T. Mang, Vienna/AT
L. Martí-Bonmatí, Valencia/ES
C. Matos, Lisbon/PT
Y. Menu, Paris/FR
G. Morana, Treviso/IT
S. Mulé, Créteil/FR
E. Neri, Pisa/IT
P. Paolantonio, Rome/IT
N. Papanikolaou, Lisbon/PT
S. Pötter-Lang, Vienna/AT
R. Pozzi Mucelli, Verona/IT
P. Prassopoulos, Thessaloniki/GR
M. Ronot, Clichy/FR
W. Schima, Vienna/AT
S. Schmidt Kobbe, Lausanne/CH
A. Schreyer, Regensburg/DE
O. Seror, Bondy/FR
S. Skehan, Dublin/IE

M. Staunton, Cork/IE
S. Stojanovic, Novi Sad/RS
J. Stoker, Amsterdam/NL
C. Stroszczynski, Regensburg/DE
A. Taibbi, Palermo/IT
B. Taouli, New York, NY/US
J.-P. Tasu, Poitiers/FR
S.A. Taylor, London/UK
D. Tolan, Leeds/UK
C. Triantopoulou, Athens/GR
V. Valek, Brno-Bohunice/CZ
F. Vernuccio, Padua/IT
V. Vilgrain, Clichy/FR
M.-P. Vullierme, Clichy/FR
M. Wagner, Paris/FR
G. Zamboni, Verona/IT
C.J. Zech, Basel/CH
M. Zins, Paris/FR

11

HEADLINE
WELCOME

Dear ESGAR members,
Dear Friends,
It is difficult to find the right and non-trivial words at the sametime to welcome you at the ESGAR annual meeting in Lisbon.
Thirty-three editions of our meeting have been organized and you
have read already numerous presidential welcome addresses.
This time, however, after two years of pandemic and online
meetings, it is much easier. I just need to say that we are very
happy, the entire ESGAR staff and myself, to meet each other inpresence again and to inform you that the maximum effort has
been made by everyone, the president of the congress first, tooffer you a special meeting, in terms of content and layout.
But this is not the easy welcome address you obviously expect
since I want to take the opportunity to share with you somepersonal ideas.
Indeed, I intend to offer you a reflection on the nature of scientificsocieties and medical congresses, which, despite what has
been said, has been completely lost in its online transposition.
A scientific society, with the annual congress, as its natural
appendix, is a community of people interested in the same orin related disciplines, who exchange their knowledge equally,making it freely available for everybody, with the common
goal represented by the progress of science and scientificeducation. In other words, it is a matter of an intense exchange ofrelationships, not of connections. The relationship is a two-way
exchange, which involves empathy between the two parts, while
the connection is only a transfer of information. Empathy canbe found in direct meetings, in physical contact (the handshake,12

the hug), in live listening, in the interaction in the room and, why
not, during coffee breaks and dinners. The online congress isthe negation of all this: it is a congress of connections, aseptic,
mediated by an electronic device, sometimes even on a delayedbasis. It is a congress that completely loses the creative,
relational, networking thrust between colleagues, very often evenfriends.
It is for these deeper reasons that I am happy to welcome you to
Lisbon and to meet you numerous again. Because whoever has
chosen to come in attendance is a person who recognizes thevalue of relationships, and not of connections, who loves real life,and not (only) digital media, who is proud to belong to a society of
GI radiologists which makes its best to serve its community in theproper way and who knows that you can find many online lessons
on the most varied topics in abdominal and gastrointestinal
radiology, but there is only one live congress like ESGAR!
I wish you all the best for the next four days.
Enjoy the meeting, enjoy Lisbon,

Andrea Laghi
ESGAR President

WELCOMEHEADLINE“Everything is worthwhile if the soul is not small.”Fernando Pessoa

Dear Colleagues,
Dear Friends,
The more I read out these words from the great Portuguese poet,the more I find a parallel with the immediate past, the present andthe future of ESGAR.
In the past months, we witnessed the big soul (and heart) of
ESGAR as the Society continued to provide education and sciencein the form of online workshops and meetings, interacting withclinical partners, to reach territories outside Europe becoming
a truly worldwide society, to enhance the role of research inmodern-day abdominal radiology and to invest in the future of thesociety by engaging young(er) members through Young ESGAR.
One of the Society’s highlights, the Annual Meeting, was held
virtually in 2020 and 2021, yet superbly fulfilling our souls in needof meeting colleagues and friends. All the efforts put into these
activities were worthwhile albeit cumbersome, again because thesoul of ESGAR is everything but little: the society could thrive evenunder quite challenging circumstances.
I address you as President of this year’s Annual Meeting and am
more than pleased that we get the chance to meet again, face
to face, in the worldwide-leading congress on abdominal andgastrointestinal radiology.

sand underneath your feet and the sea breeze in your nostrils; tovisit the fascinating monuments and museums in Belém and thecity centre; to taste the good food paired with a glass of flavoury
Portuguese wine…
But above all, I am certain it will be worthwhile to join the Annual
Meeting of ESGAR! The Scientific Programme will offer a very
attractive Postgraduate Course, placing imaging of the bowel inthe spotlight; the outstanding programme includes an extensive
choice of lecture sessions, image-guided therapy sessions,tutorials, School of ESGAR sessions and several plenary sessions,
including the Foundation Course; it also includes diverse scientificand poster sessions, as well as the Ultrasound Village. Globally,
the Programme Committee built a remarkable and eclectic
selection of scientific and educational sessions that will be worth
attending.
So, I am looking forward to host you next year in Portugal for the
33rd Annual Meeting of our Society, while meeting and greeting
friends and colleagues who share the soul of ESGAR. It shall beworthwhile!

Best wishes,
In Lisbon, a city with a very distinctive soul, I hope you will havethe opportunity to take some extra time after the sessions andthat it will be worthwhile to enjoy the nice and usually sunny
weather; to take a walk by the riverside at sunset, or to experience
it at one of the nearby beaches, feeling the smooth and white

Luís Curvo-Semedo
Meeting President

13

HONORARY FELLOWCHRISTOPH D. BECKER
GENEVA/CH

Christoph D. Becker accomplished his undergraduate medical
studies and his postgraduate training in radiology at the University
Hospital of Berne, Switzerland. After an elective year in visceralsurgery, he completed a two-year clinical fellowship in abdominalinterventional radiology at the University of British Columbia in
Vancouver, Canada. After returning to Berne he became staff
radiologist at the University Hospital and earned his academic
degree as Assistant Professor. In 1994, he was appointed to the
University Hospital of Geneva where he developed abdominalintervention and imaging, introducing innovations such as
percutaneous biliary stenting, percutaneous tumour ablation andnoninvasive magnetic resonance cholangiography. Having been
nominated associate professor and vice chair of the radiology
division in 2000, he has chaired the division since 2004. As a full
professor of radiology he also became chairman of the hospital
department of imaging and medical information sciences as well
as director of the university department of radiology. During his
chairmanship, a modern and fully digital academic department
was developed, including subspecialty divisions in major clinicalareas and with a strong multidisciplinary activity. After completionof his academic term, he was nominated honorary professor by
the faculty of medicine of Geneva university in 2019.
On a national level, he served on the board of the Swiss Societyof Radiology in many functions and positions, including society
president from 2000-2002. Meanwhile, he was awarded honorary
membership of the Swiss Society of Radiology. Today, he serves
the society for medicolegal expert services and was elected
member of the board of the Swiss federal commission forradiation protection.

14

On an international level, he has served in several scientificsocieties, including the executive board of ESGAR and as meetingpresident of ESGAR 2004 in Geneva. As a fellow of CIRSE, healso served in several committees, chaired the local organisingcommittee of CIRSE 2001 in Lucerne and obtained the European
board of interventional radiology (EBIR). In the European Societyof Radiology he has been appointed to the ESR Executive Council
and continues to serve on the ESR e-health and informatics
subcommittee.
As an academic teacher, he has been responsible for the preand postgraduate training programmes at his University. He hasorganised many international postgraduate courses including
those of ESGAR, CIRSE, ECR, and ESOR and has been nominatedas corresponding member of the Collège des Enseignants enRadiologie de France-CERF.
As primary investigator he has led multiple research projects
on diagnostic and interventional radiology funded by the Swiss
National research foundation and by the European Union. His
academic record includes over 200 scientific publications in thefield of diagnostic and interventional radiology. He has servedon the editorial and review boards of several scientific journals inradiology and has been awarded the editor’s recognition award by
the journal “Radiology”.
In recognition of his outstanding contribution to gastrointestinal
and abdominal radiology in general and ESGAR in particular,
Christoph D. Becker is awarded Honorary Fellowship of theEuropean Society of Gastrointestinal and Abdominal Radiology.

GOLD MEDALCELSO MATOS
LISBON/PT

Celso Matos studied medicine at the Medical School of the
University of Brussels, Belgium and obtained his Medical Degree
Magna Cum Laude in 1980. After a three-year fellowship inInternal Medicine at Brugmann and Erasme University Hospitals
in Brussels he started his fellowship in Radiology at the
department of Radiology at Erasme University Hospital in 1983.
As a board-certified radiologist, he joined the faculty in thisdepartment and led the MR imaging division since 1990. He
became Professor of Clinical Radiology in 2001 at Erasme
University Hospital where he made outstanding contributions
to the field of pancreatic imaging, developing novel and seminal
research especially on MR functional imaging. Celso Matos
was the creator and mentor of well-recognised dedicatededucational and research programmes of abdominal fellowship,receiving applicants from all over the world, being considered
one of the best mentors and leaders of abdominal imaging subspecialization.
In late 2015 Celso Matos moved to Lisbon to start his current
position as Head of the Imaging Department and as co-Directorof Champalimaud Research at the Champalimaud Foundation
having an instrumental role for the definition of the scientificstrategy, especially in the fields of imaging biomarkers andartificial intelligence.
Internationally, Celso Matos is a Fellow of ESGAR (European
Society for Abdominal and Gastrointestinal Radiology) andhas been its President in 2015-2017. For many years, he has
been contributing as distinguished member of many scientificcommittees, to the imaging programme of several international
postgraduate meetings especially ESGAR, ESOR and ECR andregularly co-organises many well-known radiological-clinicaleducational events. On a national level, he has been awarded thehonorary membership of the Portuguese Society of Radiology
and is a regular contributor to its postgraduate educational
programmes.
Celso Matos’ main areas of clinical and research interest
are abdominal and oncologic imaging. His main focus ismultidisciplinary research in pancreatic diseases and relateddisorders, and validation of Imaging Biomarkers for prediction of
response to cancer treatment.
Celso Matos has (co) authored over 100 peer-reviewed articles
and authored over 10 book chapters. He has been part of theAbdominal Section of the European Radiology Editorial Board andhas been appointed Associate Editor of Radiology in November
2016. He acts as peer-reviewer for, among other journals,
Radiology (awarded 5 times as distinguished reviewer), European
Radiology, Insights Into imaging, AJR, and Gut.
Celso Matos has delivered over 300 invited lectures in radiologicaland clinical society meetings around the world. He received theEuropean School of Radiology Best Teacher Award in 2014.
In recognition of his outstanding contribution to gastrointestinal
and abdominal radiology at large and to ESGAR in particular,
Celso Matos is awarded the Gold Medal of the European Societyof Gastrointestinal and Abdominal Radiology.

15

PROGRAMMEPLEASE NOTE THAT SESSIONS ARE MARKED WITH A LOGO TO
INDICATE THEIR CLASSIFICATION ACCORDING TO THE EUROPEAN
TRAINING CURRICULUM.
#LVL

I

#LVL

II

#LVL

III

First three years of training

Fourth and fifth year of training(general radiologist standard)

Subspecialty training standard

The European Training Curriculum has been published by the ESR, the European Society ofRadiology and can be found on the ESR website www.myESR.org under “Education“. This
document is fully supported by ESGAR. The classification of ESGAR 2022 sessions according totraining levels simply indicate that the session includes content of a certain training level according
to the European Training Curriculum. All sessions, regardless of the indicated level, are open for
all participants and equally recommended whether the participant is in training, board-certified
radiologist or sub-specialist.

16

OPENING CEREMONY & CONCERTTUESDAY, MAY 31

17:45 – 19:15, Auditorium I
17:45	Welcome addresses
A. Laghi, Rome/IT (ESGAR President)
L. Curvo-Semedo, Coimbra/PT (Meeting President)

18:30	ESGAR Honorary Lecture
Oesophageal cancer: making the most of imaging
V. Goh, London/UK

17:55	Musical Opening CORDIS piano & Portuguese guitar“Reflexo”, Paulo Figueiredo, Bruno Costa“Vaguear”, Paulo Figueiredo“Ladeira dos castanheiros”, Bruno Costa

19:00	Musical Conclusion CORDIS piano &Portuguese guitar“Tardes da Prainha”, Bruno Costa“Desencontros”, Paulo Figueiredo“Valsa de um sentido momento”, Bruno Costa“Variações em Lá m”, Artur Paredes

18:05	Honorary Fellowship and Gold Medal Awards
C.D. Becker, Geneva/CH
C. Matos, Lisbon/PT
18:20	Music Interlude CORDIS piano & Portuguese guitar“Calmaria dos dias”, Bruno Costa“Coimbra Iluminada”, Paulo Figueiredo“Correria”, Paulo Figueiredo

CORDIS piano & Portuguese guitar
Paulo Figueiredo’s Piano and Bruno Costa’s Portuguese Guitar merge with passion and intensity in a novel aesthetic approach, revealing
unknown facets of some of the classical Coimbra Guitar pieces. Both instruments fuse in a constant dialogue of strings, meanderingand exploring the harmonic and rhythmic exuberance of the works of celebrated composers. With notable skill, their essence is
melodically laboured into new and all-embracing revelations.
From the heart.
With our soul.
For the spirit.

17

HONORARY LECTURES
Tuesday, May 31
18:30 – 19:00 / ESGAR Honorary Lecture

Thursday, June 2
16:30 – 17:00 / SAR Honorary Lecture

HL 1

HL 3

Auditorium I

Auditorium I

Moderator: A. Laghi, Rome/IT

Moderator: A. Laghi, Rome/IT

Oesophageal cancer: making the most of imaging
V. Goh, London/UK

Imaging evaluation before surgical resection
K.M. Elsayes, Houston, TX/US

PLENARY SESSIONS
Wednesday, June 1
16:30 – 16:45
PS 1aAwards Ceremony

Thursday, June 2
17:00 – 18:00
Auditorium I

Moderator: A. Laghi, Rome/IT

PS 3
Auditorium I
Clinical Files Session: live interpretation of
abdominal cases
Moderator: G. Brancatelli, Palermo/IT

European Radiology Awards
Y. Menu, Paris/FR
Insights into Imaging Award
L. Martí-Bonmatí, Valencia/ES

Panellists:
N. Bastati-Huber, Vienna/AT
K. Cortis, Msida/MT
R. Pozzi Mucelli, Stockholm/SE
F. Wessels, Utrecht/NL

Wednesday, June 1
16:45 – 18:00

Friday, June 3
14:00 – 16:00

PS 2
Auditorium I
One case – Three lessons: reflecting on my error

PS 4
Auditorium I
Nick Gourtsoyiannis’ Foundation Course 1 –Rad-path correlation: Pancreas

Moderators: M. Morrin, Dublin/IE; D. Tolan, Leeds/UK
Opening up: making the first steps in my department
M. França, Porto/PT
Does leading from the front just mean a long way to fall?
A. Brady, Cork/IE
Panellists:
M. Zins, Paris/FR
I. Zealley, Dundee/UK
F. Labruto, Sydney, NSW/AU
C. Ewertsen, Copenhagen/DK
C. Chew, Glasgow/UK
M. Radzina, Riga/LV

Moderators: A. Torregrosa Andrés, Valencia/ES;
V. Vandecaveye, Leuven/BE
Pancreatic cystic tumours
N. Kartalis, Stockholm/SE; R.C. Oliveira, Coimbra/PT
Non-adenocarcinoma pancreatic solid tumours
G. Zamboni, Verona/IT; R.C. Oliveira, Coimbra/PT

PS 4
Auditorium I
Nick Gourtsoyiannis’ Foundation Course 2 –Rad-path correlation: GI tumours
Moderators: A. Torregrosa Andrés, Valencia/ES;
V. Vandecaveye, Leuven/BE
Non adenocarcinoma gastric cancer
G. Tardáguila de la Fuente, Vigo/ES; S. Landolfi, Barcelona/ES

18

Non-epithelial bowel tumours
D. Armario, Barcelona/ES; S. Landolfi, Barcelona/ES

PROGRAMME OVERVIEW – TUESDAY, MAY 31, 2022
Auditorium I
07:30-08:00
08:00-08:30
08:30-09:00
09:00-09:30

PG 1
Revisiting luminal Crohn’s disease in 2022

09:30-10:00
10:00-10:30
10:30-11:00
11:00-11:30

PG 2
Acute bowel in the ER (and OR): ischemic disease

11:30-12:00
12:00-12:30
12:30-13:00

Industry Symposium

13:00-13:30
13:30-14:00
14:00-14:30
14:30-15:00

PG 3
Imaging the postoperative GI tract: where to look

15:00-15:30
15:30-16:00
16:00-16:30
16:30-17:00

PG 4
Rectal cancer

17:00-17:30
17:30-18:00
18:00-18:30
18:30-19:00
19:00-19:30

PS 1
Opening of ESGAR 2022
HL 1
ESGAR Honorary Lecture

19:30-20:00

19

TUESDAY, MAY 31, 2022
08:30 – 10:00 / Postgraduate Course

14:00 – 15:30 / Postgraduate Course

PG 1
Auditorium I#LVL
Revisiting luminal Crohn’s disease in 2022

PG 3
Auditorium I
Imaging the postoperative GI tract: where to look #LVL

Moderators: A. Laghi, Rome/IT;
L. Curvo-Semedo, Coimbra/PT

Moderators: S. Stojanovic, Novi Sad/RS;
T. Lehtimäki, Helsinki/FI

II

08:30	Imaging features of CD and alternative diagnoses: how
to get it right
J. Tielbeek, Amsterdam/NL
08:45	Characterisation of strictures: inflammatory, fibrotic
or both?
S.A. Taylor, London/UK
09:00	Medical or surgical treatment? What the clinicians
want to know
F. Magro, Porto/PT; M. Machado, Porto/PT
09:45	Case-based discussion

II

14:00	Following the surgeon’s hands: surgical procedures andnormal post-op anatomy
N. Figueiredo, Lisbon/PT
14:15	To re-operate or not to re-operate: early complications
D. Tolan, Leeds/UK
14:30	It still hurts: late-onset complications
M. Laniado, Dresden/DE
14:45 Case-based discussion

16:00 – 17:30 / Postgraduate Course
10:30 – 12:00 / Postgraduate Course

PG 4
Rectal cancer

PG 2
Auditorium I
Acute bowel in the ER (and OR): ischemic disease #LVL
Moderators: M. Zins, Paris/FR; C.J. Zech, Basel/CH

II

10:30	The many faces of acute mesenteric ischemia
M. Ronot, Clichy/FR
10:45	How to manage: is surgery always needed?
E.S. van Hattum, Utrecht/NL
11:00	When and how can interventional radiology help?
E.-J. Vonken, Utrecht/NL
11:15 Case-based discussion

Moderators: R.G.H. Beets-Tan, Amsterdam/NL;
S. Gourtsoyianni, Athens/GR

Auditorium I
#LVL

II

16:00	Optimising the rectal MRI report: “pearls and pitfalls”
E. Dresen, Leuven/BE
16:15	Radiologic-pathologic correlation: what can theradiologist learn from it?
L. Blomqvist, Stockholm/SE
16:30	Impact of key aspects of the MRI report in patientmanagement: a surgeon’s perspective
G. Beets, Amsterdam/NL
16:45 Case-based discussion

12:15 – 13:15 / Industry Symposium
17:45 – 19:15 / Plenary Session
SY 1
Industry-sponsored Symposium
For details please refer to page 61.

20

Auditorium I
PS 1
ESGAR 2022 – Opening Ceremony

Auditorium I

PROGRAMME OVERVIEW – WEDNESDAY, JUNE 1, 2022
08:00-08:30

08:30-09:00

Auditorium I

Auditorium VI

Auditorium II

Auditorium III

ET 1
Gaps in knowledge
in CT/MRI LI-RADS
v2018

ET 2
Local colon cancer
staging – time to up
my gameET 3
Don’t forget the
appendix

ET 4
Many facesof abdominal
lymphoma

09:00-09:30

LS 2
ESGAR – ESUR Joint
LS 1
Session: Artificial
09:30-10:00 State-of-the-art liverintelligence inimaging in 2022
abdominal radiology:
where are we now?
10:00-10:30

10:30-11:00

11:00-11:30

11:30-12:00

SOE 1
Acute abdomen:bowel blockages!

ET 9
Atypical HCC – canwe diagnose it?
(Richard Baron
Tutorial)

ET 7
Imaging internal
herniasAuditorium VIII

Room 5AET 5
ET 6
Groin pain for the GI
Pelvic floor disorders
radiologist

USV 1
Keynote Lecture

USV 2
Keynote Lecture
SS 1
Colorectal cancer

SS 2
Pancreatic
Ademocarcinoma

USV 3
Keynote Lecture

ET 8
Anorectal squamouscancer – not justrectal cancer!

IGT 1
How do I do it – IRprocedures foreveryday radiologicalpractice

Room 5C

SS 3
Rectal cancer
staging

12:00-12:30

ET 10
ES 1
Oesophageal cancer
From submission to
publication – all you
want to know from
Editors in Chief
ET 11

USV 4
Hands-on Training

Not Crohn’s disease!
Imaging the other small
bowel diseases

12:30-13:00

13:00-13:30

Industry
Symposium

Industry
Symposium

TC 1
Tricky cases

RT 1
How to criticallyreview and grade thequality of scientific
literature

13:30-14:00

Industry
Lecture14:00-14:30

14:30-15:00

15:00-15:30

LS 3
Imaging in blunt
abdominal trauma

15:30-16:00

LS 4
Staging (andrestaging)nodal disease
in abdominal
malignancies

ET 12
Non-tumoral
liver injury after
chemotherapy

ET 13
Portal veinthrombosis

USV 5
Keynote Lectures
SS 4
Hepatocellular
carcinoma detection

SOE 2
Unravelling
mysteries of themesentery
USV 6
Hands-on Training

16:00-16:30

16:30-17:00

17:00-17:30

17:30-18:00

PS 1a

PS 2
One case – Threelessons: reflecting
on my error

18:00-18:30

General Assembly
18:00-19:00

21

WEDNESDAY, JUNE 1, 2022
08:00 – 08:45 / ESGAR Tutorials

09:00 – 10:30 / Lecture Session

ET 1
Auditorium I#LVL
Gaps in knowledge in CT/MRI LI-RADS 2018:
II
Case-based review

LS 1State-of-the-art liver imaging in 2022

C. Sirlin, San Diego, CA/US; V. Chernyak, Boston, MA/US

ET 2
Auditorium VI
Local colon cancer staging – time to up my game #LVL
II

P. Paolantonio, Rome/IT; V. Goh, London/UK

ET 3
Don’t forget the appendix

Auditorium II
#LVL

II

M. Scheurkogel, The Hague/NL; J.B.C.M. Puylaert,
The Hague/NL

ET 4
Many faces of abdominal lymphoma

Auditorium III
#LVL

II

#FROM MY WORKSTATION

E. de Kerviler, Paris/FR; E. Biscaldi, Genoa/ITET 5Groin pain for the GI radiologist

Auditorium I

Moderators: F. Caseiro Alves, Coimbra/PT; A. Ba-Ssalamah,
Vienna/AT

#LVL

II

09:00	Fast liver MRI protocols in oncologic and cirrhotic
patients: a wave of the future or a soap bubble?
B. Taouli, New York, NY/US
09:20	Updates on hepatocellular adenomas: diagnosis,
classification, and follow-up
F. Vernuccio, Padua/IT
09:40	Hepatobiliary phase MRI: a room with athousand mirrors
S. Pötter-Lang, Vienna/AT
10:00	Immunotherapy and liver cancer: hope and gaps in the
management of liver tumours
C. Dromain, Lausanne/CH
10:20 Questions and answers

Auditorium VIII
#LVL

II

A. Plumb, London/UK; S.M. Erturk, Istanbul/TR

ET 6
Room 5A#LVL
Pelvic floor disorders #STRUCTURED REPORTINGII

G. Masselli, Rome/IT; F. Maccioni, Rome/IT

LS 2
Auditorium VI
ESGAR – ESUR Joint Session: Artificial#LVL
II
intelligence in abdominal radiology:
where are we now?
Moderators: C.D. Becker, Geneva/CH; N. Papanikolaou, Lisbon/PT
Presidents: A. Laghi, Rome/IT; M.M. Otero-García, Vigo/ES

08:00 – 08:45 / Ultrasound Village
USV 1
Keynote Lecture

09:00 – 10:30 / Lecture Session

Room 5C

09:00	Focal liver lesions
J. Sosna, Jerusalem/IL
09:15	Kidney
A. Ljimani, Düsseldorf/DE
09:30	Rectum
J. Van Griethuysen, Amsterdam/NL
09:45	Prostate
T. Penzkofer, Berlin/DE
10:00 Case-based discussion

Room 5C

09:00 – 09:45 / ESGAR Tutorials

08:00	Welcome and introduction to the US Village
M. Ramalho, Almada/PT
08:05	Practical use of abdominal CEUS
D. Cokkinos, Athens/GR

08:50 – 09:30 / Ultrasound Village
USV 2
Keynote Lecture

08:50	New technological developments in abdominal US
W. Ibrahim, Jülich/DE

22

ET 7
Auditorium II#LVL
Imaging internal hernias #FROM MY WORKSTATION
I. Millet, Montpellier/FR; J. Nederend, Eindhoven/NLIIWEDNESDAY, JUNE 1, 2022
09:40 – 10:30 / Ultrasound Village
USV 3
Keynote Lecture

Room 5C

09:40	Abdominal US the era of CT and MRI
J.B.C.M. Puylaert, The Hague/NL

10:00 – 10:45 / ESGAR Tutorials
ET 8
Anorectal squamous cancer – not justrectal cancer!

Auditorium II
#LVL

II

H. Lambie, Leeds/UK; D. Lambregts, Amsterdam/NL

09:00 – 10:30 / Scientific Session
SS 1
Colorectal Cancer

Auditorium III

Moderator: S. Nougaret, Montpellier/FR
09:00	SS 1.1 Improving the appropriateness of CT
colonography referrals
A.O. Yousif1, M. Ismail2, R. Vinayagam3; 1Leeds/UK,
2
Scarborough/UK, 3Bradford/UK
09:08	SS 1.2 Post-imaging colorectal cancers: evaluation of
a 10-year experience of CT colonography in a highvolume centre
D. Tolan1, P. Melling1, J. Taylor1, N.E. Burr2, P. Quirke1,
E. Morris3; 1Leeds/UK, 2Wakefield/UK, 3Oxford/UK
09:16	SS 1.3 Inter-reader agreement in staging colon cancer
patients: the usefulness of CECT
C. Maino1, M. Ragusi2, T. Giandola2, R. Corso1, C. Talei
Franzesi1; 1Milan/IT, 2Monza/IT
09:24	SS 1.4 Fully automated body composition biomarkers
for predicting overall survival at staging CT forcolorectal cancer
S.G. Pickhardt1, J. Garrett1, A.A. Perez1, R. Zea1, M.H. Lee1,
M.G. Lubner1, R.M. Summers2, P.J. Pickhardt1; 1Madison,
WI/US, 2Bethesda, MD/US
09:32	SS 1.5 Prediction of nodal metastasis in right-sided
colon cancer with node for node correlation: a novel
approach using complete mesocolic excision withcentral vascular ligation
M. Widmar, H. Thompson, J.B. Yuval, C. Firat, J. Shia,
J. Zheng, M. Capanu, A. Cercek, J. Garcia-Aguilar,
M.J. Gollub, D.D. Bates; New York, NY/US

09:40	SS 1.6 A new insight into mismatch repair status,
systemic inflammatory markers and tumour
differentiation and the implications for nodal staging ofcolon cancer with CT
J. Platt, J. Ansett, J. Seligmann, N. West, D. Tolan; Leeds/UK
09:48	SS 1.7 Is CT radiomics superior tomorphological evaluation for PN0
characterization? A pilot study in stage II colon
adenocarcinoma
I. Nacci, M. Zerunian, M. Polici, D. Caruso, E. Iannicelli,
A. Laghi; Rome/IT
09:56	SS 1.8 MRI staging of colon cancer
S.R. Rafaelsen, C. Dam, C.A. Vagn-Hansen, J. Møller,
H. Rahr, M. Sjöström, J. Lindebjerg, T.F. Hansen,
M.R. Pedersen; Vejle/DK
10:04	SS 1.9 Performance evaluation of CT as a biomarker
for neoadjuvant chemotherapy in colon cancer:
FOxTROT experience
D. Tolan1, D. Morton2, M. Seymour1, P. Quirke1,
K. Handley2, L. Magill2, N. West1, J. Seligmann1; 1Leeds/UK,
2
Birmingham/UK

09:00 – 10:30 / Scientific Session
SS 2
Pancreatic adenocarcinoma

Auditorium VIII

Moderators: C. Matos, Lisbon/PT; M.A. Bali, Brussels/BE
09:00	SS 2.1 Higher volume growth rate is associatedwith the development of worrisome features inpatients with branch duct-intraductal papillary
mucinous neoplasms
F. Fedeli, D. Palatresi, G. Danti, T. Innocenti, A. Galli,
V. Miele; Florence/IT
09:08	SS 2.2 Preclinical diffusion tensor imaging of thepancreas for the characterization of pre-malignant
lesions
C. Bilreiro, F.F. Fernandes, R.V. Simões, A. Ianus,
C. Chavarrias, M. Castillo-Martin, T. Carvalho, C. Matos,
N. Shemesh; Lisbon/PT
09:16	SS 2.3 Efficacy of contrast-enhanced magnetic
resonance imaging in the differentiation between
malignant and benign pancreatic cystic neoplasms
A. Kristic, A. Messner, N. Bastati-Huber, S. Pötter-Lang,
R. Ambros, M. Schindl, A. Ba-Ssalamah; Vienna/AT

23

WEDNESDAY, JUNE 1, 2022
09:24	SS 2.4 Coronary artery calcium score as a predictor ofmajor adverse cardiac events in patients undergoing
pancreatic surgery
B.I. van Rosmalen, M.A. Brouwer, A.M. Hogenes, M. Meij,
M. Van der Kolk, C.J. Van Laarhoven, M. Prokop,
J.J. Hermans; Nijmegen/NL
09:32	SS 2.5 A CT-based radiomics study using tumourand vessel features to predict non-resectability inchemonaive patients with cancer of the pancreatic head
G. Litjens1, J.J. Hermans1, J. Broekmans2, T. Boers2,
M. van den Hurk1, D. Ozdemir1, C. Schaik1, M. Janse3,
E. van Geenen1, K. van Laarhoven1, M. Prokop1,
H. Huisman1, P. de With2, F. van der Sommen2;
1
Nijmegen/NL, 2Eindhoven/NL, 3Utrecht/NL
09:40	SS 2.6 Diagnostic performance of MRI to predict theresectability of pancreatic adenocarcinoma according
to National Comprehensive Cancer Network criteria
L. Soydan, C. Karabiber Deveci; Istanbul/TR
09:48	SS 2.7 Pancreatic ductal adenocarcinoma: CT
texture analysis of the area lesion to predictmetastasis
L. Geraci, L. Tomaiuolo, C. Longo, D. Autelitano,
M. Todesco, A. Carli, F. Verrengia, A. Olivieri, R. De Robertis,
M. D‘Onofrio; Verona/IT
09:56	SS 2.8 Radiogenomics of pancreatic ductal
adenocarcinoma
C. Longo, L. Tomaiuolo, L. Geraci, G. Aluffi, M. Todesco,
D. Autelitano, V. Rossi, F. Cicalo‘, M. D‘Onofrio; Verona/IT
10:04	SS 2.9 Comparison between CT texture data,
resection margin status and clinical outcomes inpancreatic adenocarcinoma resected after induction
chemotherapy and neoadjuvant stereotactic bodyradiation therapy
R. De Robertis, L. Geraci, L. Tomaiuolo, D. Autelitano,
M. Todesco, A. Carli, C. Longo, M. D‘Onofrio; Verona/IT
10:12	SS 2.10 Diffusion-weighted magnetic resonanceimaging in restaging of pancreatic ductal
adenocarcinoma after neoadjuvant therapy:
a pilot study
B. Miseur, V. Vandecaveye, L. Cockmartin, B. Topal,
E. Van Cutsem, T. Roskams, R. Dresen; Leuven/BE

24

11:00 – 12:30 / School of ESGAR
SOE 1
Acute abdomen: bowel blockages!

Auditorium I

Moderators: G. Maskell, Truro/UK, S. Schmidt Kobbe,
Lausanne/CH

#LVL

II

11:00	Blocked small bowel – how to cope?
P. Taourel, Montpellier/FR
11:30	Blocked large bowel – how to cope?
M. Morrin, Dublin/IE
12:00 Case-based discussion

11:00 – 12:00 / ESGAR Tutorials
ET 9
Auditorium VI#LVL
Richard Baron Tutorial: Atypical HCC – can weIIdiagnose it? #FROM MY WORKSTATION
R. Albazaz, Leeds/UK; A. Furlan, Pittsburgh, PA/US

11:00 – 12:30 / Image Guided Therapy
IGT 1
Auditorium II#LVL
How do I do it – IR procedures for everyday
IIradiological practiceModerator: M. Krokidis, Athens/GR
11:00	Anesthesiology in IR procedures
V. Almeida, Coimbra/PT
11:15	Liver biopsy
M. Dioguardi Burgio, Villejuif/FR
11:30	Cholecystostomy
M. Zins, Paris/FR
11:45	Abscess drainage
A. Lowe, Taunton/UK
12:00	How to deal with bleeding complications
R. Garcia Marcos, Valencia/ES
12:15 Questions and answers

WEDNESDAY, JUNE 1, 2022
11:00 – 12:30 / Scientific Session
SS 3
Rectal cancer staging

Auditorium III

Moderators: P. Popovic, Ljubljana/SI; C. Sofia, Messina/IT
11:00	SS 3.1 Rectal MRI quality assessment byradiographers: do they see it the same way
as a radiologist?
D. Tolan1, J. Taylor1, H. Rossington1, D. Lambregts2,
P. Quirke1, P.J. Brown3; 1Leeds/UK, 2Amsterdam/NL,
3
York/UK
11:08	SS 3.2 Value of pelvic CT in addition to MRI todifferentiate between rectal and sigmoid cancer on
imaging using the sigmoid take-off as a landmark
N. Bogveradze1, M. Maas1, N. El Khababi1, N.W. Schurink1,
M.J. Lahaye1, F. Bakers2, P.J. Tanis1, M. Kusters1, G.L. Beets1,
R.G.H. Beets-Tan1, D. Lambregts1; 1Amsterdam/NL,
2
Maastricht/NL
11:16	SS 3.3 MRI staging of ano-rectal malignancy —a reporting dilemma: is it adenocarcinoma or
squamous cell carcinoma?
A. Chandramohan, K. Sathyakumar, A. Eapen, R. Mittal;
Vellore/IN
11:24	SS 3.4 Staging of early rectal cancer, the diagnostic
performance of MRI to identify tumours eligible for
local excision
E. Viktil; Oslo/NO
11:32	SS 3.5 High-resolution diffusion-weighted imaging
for the evaluation of extramural tumours invasion inprimary rectal cancer
S.H. Kim, E.J. Park, S.J. Jo, J.-H. Yoon; Busan/KR
11:40	SS 3.6 Intraindividual comparison of diagnostic
efficacy of orally administered liver-specificcontrast agent Mangoral (Orviglance) (manganesechloride tetrahydrate) and intravenous gadobenate
dimeglumine (Multihance) in patients with colorectal
liver metastases
K. Shamsi1, T. Brismar2, N. Kartalis2, C. Bjartmar3;
1
Conshohocken, PA/US, 2Stockholm/SE, 3Malmö/SE
11:48	SS 3.7 Impact of a quality improvement programme onrectal cancer MRI reporting in clinical practice: does it
improve report content?
C. Muthoo1, P.J. Brown1, H. Rossington2, S. Alderson2,
P. Quirke2, D. Tolan2; 1York/UK, 2Leeds/UK
11:56	SS 3.8 Upper abdominal imaging in rectal cancer
staging MRI
C. Muthoo, M. Ting, J.D. Coates, P.J. Brown; York/UK

12:04	SS 3.9 Accuracy of endorectal ultrasound (EUS) in
rectal cancer and the impact this has on management
A.O. Yousif1, N. Jagirdar2, E. Teodorescu-Arghezi2;
1
Leeds/UK, 2Bradford/UK
12:12	SS 3.10 MRI surveillance after treatment withcontact X-ray brachytherapy for rectal cancer:
preliminary results
P. Custers, M. Maas, D. Lambregts, R.G.H. Beets-Tan,
I. Huibregtse, M. van Leerdam, D. van der Reijd, G.L. Beets,
F. Peters, C. Marijnen, B. van Triest; Amsterdam/NL
12:20	SS 3.11 Role of MRI for early tumor response
evaluation in anal cancer after 5 weeks ofchemoradiotherapy to guide boost strategies
D.M. Lambregts, E. van den Hurk, F.P. Peters, F.E. Voncken,
B.A. Grotenhuis, C.L. Deijen, B. van Triest; Amsterdam/NL

11:00 – 12:30 / Editorial Session
ES 1
Auditorium VIII
From submission to publication – all you want to #LVL
IIknow from Editors in Chief
Moderator: R.G.H. Beets-Tan, Amsterdam/NL
11:00	The various types of scientific publications and its
logicsJ. Drenth, Nijmegen/NL (Editor in Chief, UEG Journal)
11:15	What happens after my manuscript is submitted?
Y. Menu, Paris/FR (Editor in Chief, European Radiology)
11:30	How do we measure scientific impact?
L. Martí-Bonmatí, Valencia/ES (Editor in Chief, Insights into
Imaging)
11:45 Panel discussion

11:00 – 11:45 / ESGAR Tutorials
ET 10
Room 5A#LVL
Oesophageal cancer #STRUCTURED REPORTING
D. Tamandl, Vienna/AT; S. Withey, London/UK

II

12:00 – 12:45 / ESGAR Tutorials
ET 11
Room 5A#LVL
Not Crohn’s disease! Imaging the other smallIIbowel diseases
L. Guimarães, Porto/PT; S. Gourtsoyianni, Athens/GR

25

WEDNESDAY, JUNE 1, 2022
11:00 – 12:00 / Ultrasound Village

12:45 – 13:45 / Research Tutorials

USV 4
Room 5C
Basic „hands-on“ US (5 US machines, 5 models,
5 tutors)

RT 1
Auditorium III#LVL
Understanding the level of evidence – howIIto critically review and grade the quality ofscientific literature

Tutors:D. Cokkinos, Athens/GR
J.B.C.M. Puylaert, The Hague/NL
W. Ibrahim, Jülich/DE
I. Vanhooymissen, The Hague/NL
M. Scheurkogel, The Hague/NL

Moderators: D. Lambregts, Amsterdam/NL; S. Nougaret,
Montpellier/FR
12:45	Understanding the level of evidence – how to criticallyreview and grade the quality of scientific literature
M. Maas, Amsterdam/NL; S. Bipat, Amsterdam/NL
13:25 Questions and answers

12:45 – 13:45 / Industry Symposium
13:45 - 14:30 / Industry Lecture
SY 2
Industry-sponsored Symposium

Auditorium I
ISWS 1
Industry-sponsored Lecture

For details please refer to page 63.

Room 5A

For details please refer to page 68.

SY 3
Industry-sponsored Symposium

Auditorium VI

For details please refer to page 65.

14:00 – 15:30 / Ultrasound Village

12:45 – 13:30 / Tricky Cases

USV 5
Keynote Lectures

TC 1
Tricky cases from my day job

Auditorium II

Moderators: C. Reiner, Zurich/CH; R. Cannella, Palermo/IT
12:45	Syndromes in abdominal imaging
S. Malekzadeh, Sion/CH
12:54	When things can turn bad unexpectedly...
P. Rodríguez Carnero, Madrid/ES
13:03	A changing adrenal gland
B. Rea, Sheffield/UK
13:12	Unusual hepatic cyst
F. Castagnoli, Brescia/IT
13:21	A challenging mimic
C. Maino, Milan/IT

26

Room 5C

14:00	US of liver (benign)
O. Lucidarme, Paris/FR
14:45	US of liver (malignant)
C. Aubé, Angers/FR

#LVL

II

14:30 – 16:00 / Lecture Session
LS 3
Imaging in blunt abdominal trauma

Auditorium I

Moderators: H. Alexandrino, Coimbra/PT; P. Wiggermann,
Braunschweig/DE
14:30	Liver and hepatobiliary tract
S. Schmidt Kobbe, Lausanne/CH
14:50	Spleen
P. Wiggermann, Braunschweig/DE
15:10	Pancreas, bowel and mesentery
M. Scaglione, Castelvolturno/IT
15:30 Case-based discussion

WEDNESDAY, JUNE 1, 2022
14:30 – 16:00 / Lecture Session

14:30 – 16:00 / Scientific Session

LS 4
Auditorium VI#LVL
Staging (and restaging) nodal disease inIIabdominal malignancies

SS 4
Hepatocellular carcinoma detection

Moderators: L. Costa, Belo Horizonte/BR; L.H. Ros Mendoza,
Zaragoza/ES
14:30	Hepatobiliopancreatic malignancies
R. Manfredi, Rome/IT
14:50	Colorectal cancer
S. Nougaret, Montpellier/FR
15:10	Lymphoma
N. Courcoutsakis, Alexandroupolis/GR
15:30 Case-based discussion

14:30 – 15:15 / ESGAR Tutorials
ET 12
Auditorium II#LVL
Non-tumoral liver injury after chemotherapy orIIradiation therapy
C. Mihl, Maastricht/NL; D.-M. Koh, Sutton/UK

15:30 – 16:15 / ESGAR Tutorials
ET 13
Portal vein thrombosis
D. Akata, Ankara/TR; J.-P. Tasu, Poitiers/FR

Auditorium II
#LVL

II

Auditorium III

Moderators: K. Chupetlovska, Sofia/BG; M. Garbajs, Ljubljana/SI
14:30	SS 4.1 Noninvasive diagnosis of small HCC: canimaging hallmarks be extracted from different imaging
modalities?
A. Chouard1, A. Paisant2, V. Vilgrain1, C. Aubé2, M. Ronot1;
1
Clichy/FR, 2Angers/FR
14:38	SS 4.2 Detection of early-stage HCC with abbreviatedgadoxetate MRI: comparison with ultrasound -pilot study
N. Vietti Violi1, M. Wagner2, C. Besa3, M. Hulkower4, M.
Schwartz4, S. Lewis4, K. Sigel4, B. Taouli4; 1Lausanne/CH,
2
Paris/FR, 3Santiago/CL, 4New York, NY/US
14:46	SS 4.3 Fat-containing liver lesions: are usual MRI
diagnostic criteria of both malignant and benign
primary liver lesions still applicable?
E. Reizine, S. Mulé, G. Amaddeo, R. Kharrat, A. Laurent,
J. Calderaro, A. Luciani; Créteil/FR
14:54	SS 4.4 Influence of the imaging modality of detectionof hepatic nodules on the noninvasive diagnosis of
HCC in cirrhotic patientsA. Paisant1, M. Roux1, C. Cassinotto2, C.M. Canivet1,
O. Sutter1, V. Vilgrain3, C. Aubé1; 1Angers/FR,
2
Castelnau-le-Lez/FR, 3Clichy/FR
15:02	SS 4.5 Adherence to LI-RADS and EASL high-risk
population criteria: a systematic review
R. Cannella1, M. Dioguardi Burgio2, R. Sartoris3, V. Vilgrain3,
M. Ronot3; 1Palermo/IT, 2Paris/FR, 3Clichy/FR
15:10	SS 4.6 Fat hepatocellular carcinoma in patientswith cirrhosis: a new diagnostic algorithm
proposalA. Delagnes1, M. Roux1, V. Vilgrain2, B. Guiu3, V. Laurent4,
O. Sutter5, I. Bricault6, H. Trillaud7, C. Aubé1, A. Paisant1;
1
Angers/FR, 2Clichy/FR, 3Montpellier/FR,
4
Vandoeuvre-lès-Nancy/FR, 5Bobigny/FR, 6Grenoble/FR,
7
Bordeaux/FR
15:18	SS 4.7 Positive predictive value of hepatocellular
carcinoma surveillance ultrasound depends on thepresence of cirrhosis
J. Tse, L. Shen, T. Liang, L. Yoon, A. Kamaya;
Stanford, CA/US

27

WEDNESDAY, JUNE 1, 2022
15:26	SS 4.8 Impact of COVID-19 pandemic on hepatocellular
carcinoma ultrasound surveillance volumes at a livertransplant center
J. Tse, L. Shen, L. Yoon, A. Kamaya; Stanford, CA/US
15:34 	SS 4.10 Determining the radiological outcome ofsubcentimeter-sized hepatic nodules demonstrating
non-rim arterial phase hyperenhancement in atrisk patients under surveillance for hepatocellular
carcinoma in the Indian population
D. Mehta1, D. Lokhandwala1, S. Sabnis1, S. Siddiqui1,
S. Nellore2, S. Jalkote1, K. Ganesan1; 1Mumbai/IN,
2
Navi Mumbai/IN

16:30 – 16:45 / Plenary Session
PS 1aAwards Ceremony

Auditorium I

Moderator: A. Laghi, Rome/IT
16:30	European Radiology Awards
Y. Menu, Paris/FR
16:40 	Insights into Imaging Award
L. Martí-Bonmatí, Valencia/ES

16:45 – 18:00 / Plenary Session
14:30 – 16:00 / School of ESGAR

PS 2
Auditorium I
One case – Three lessons: reflecting on my error

SOE 2
Auditorium VIII
#LVL
Unravelling mysteries of the mesentery

Moderators: M. Morrin, Dublin/IE; D. Tolan, Leeds/UK

Moderators: A. Palkó, Szeged/HU; I. Boulay Coletta, Paris/FR

16:45	Opening up: making the first steps in my department
M. França, Porto/PT
16:54 	Does leading from the front just mean a long way to fall?
A. Brady, Cork/IE
17:03 	Case presentations:M. Zins, Paris/FR
I. Zealley, Dundee/UK
F. Labruto, Sydney, NSW/AU
C. Chew, Glasgow/UK
M. Radzina, Riga/LV
17:45 Discussion

II

14:30	Mesenteric neoplasms
P. Prassopoulos, Thessaloniki/GR
15:00	Non-neoplastic mesenteric diseases and approach todifferential diagnosis
C. Stoupis, Maennedorf/CH
15:30 Case-based discussion

15:30 – 16:30 / Ultrasound Village
USV 6
Abdominal US Hands-on training(5 US machines, 5 models, 5 tutors)
Tutors:C. Aubé, Angers/FR
O. Lucidarme, Paris/FR
D. Cokkinos, Athens/GR
J.B.C.M. Puylaert, The Hague/NL
M. Scheurkogel, The Hague/NL

28

Room 5C
18:00 – 19:00
ESGAR GENERAL ASSEMBLY
For ESGAR Members in good standing only

Auditorium II

PROGRAMME OVERVIEW – THURSDAY, JUNE 2, 2022
Auditorium I
08:00-08:30

08:30-09:00

Auditorium II

Auditorium III

ET 14
ET 15
ET 16
ET 17
Commonly missed
Screening with
Imaging in patients
Paediatric liverlesions when per- abdominal CT using with colorectal liver diseases: challengforming abdominal
AI tools
metastases
ing cases

09:00-09:30

09:30-10:00

Auditorium VI

LS 5
Gastric cancer:
what’s new?

10:00-10:30

ET 20
LS 6
How non-invasive PET/MRI: ready forclinical practice?
tests are used
for the evaluationof chronic liverdisease: guidelines
ET 21
and beyond
GEP-NET: challenging cases

SS 5Interventional
Radiology

Auditorium VIII

Room 5A

Room 5C

ET 18
Imaging chronic
mesenteric ischemia

ET 19
Spleen: challenging
cases

USV 7
Keynote Lecture

USV 8
Keynote Lecture

SS 6
Bowel
Inflammation

10:30-11:00

11:00-11:30

11:30-12:00

SOE 3
Acute abdomen:a pain in the pancreas!

ET 22
Anatomical variantsof the vessels and
IGT 2
HCC – Role of radi- bile ducts: implicaology for diagnosis tions for surgery
and treatment

SS 7
Pancreas

SS 8
Biliary tract/NET

12:00-12:30

12:30-13:00

13:00-13:30

TC 2
Tricky cases

Industry
Symposium

ET 23
CT colonography
difficult cases

USV 9
US Live Demo

USV 10Hands-on Training
ET 24
Vascular and biliarycomplications after
liver transplant

RT 2
Reading another AI
paper? – what toreally look for

13:30-14:00

14:00-14:30

14:30-15:00

15:00-15:30

LS 7
In and around theduodenum

15:30-16:00

USV 11
Keynote Lectures
SS 9
Small bowel and
colon

SOE 4
Hot livers andgallbladders

ET 26

New insights on imaging and managementof gallbladder

16:00-16:30

16:30-17:00

LS 8
Tumour response
in abdominal
imaging: how toappraise?

ET 25
Optimising your CT
technique in acuteabdomen

USV 12
Hands-on Training

HL 3
SAR HL

17:00-17:30

17:30-18:00

PS 3
Clinical Files

18:00-18:30

29

THURSDAY, JUNE 2, 2022
08:00 – 08:45 / ESGAR Tutorials

08:50 – 10:20 / Ultrasound Village

ET 14
Auditorium I#LVL
Commonly missed lesions when performingIIabdominal CT/MRI: who, what, when, where
and why? #SINGLE TOPIC

USV 8
Keynote Lectures

Y. Menu, Paris/FR

ET 15
Auditorium VI#LVL
Screening with abdominal CT using AI tools:III
are we ready yet? #SINGLE TOPIC

Room 5C

08:50	US of acute gynaecological abdomen
M. Scheurkogel, The Hague/NL
09:35	US of Crohn‘s disease
E. Coerkamp, The Hague/NL

P.J. Pickhardt, Madison, WI/US; E. Neri, Pisa/IT

09:00 – 10:30 / Lecture Session

ET 16
Auditorium II#LVL
Imaging in patients with colorectal liverII
metastases

LS 5
Gastric cancer: what‘s new?

Auditorium I

Moderators: S. Romano, Pozzuoli/IT; A. Riddell, London/UK

#LVL

II

A. Cieszanowski, Warsaw/PL; L. Milot, Lyon/FR

ET 17
Auditorium III#LVL
Paediatric liver diseases: challenging cases#FROM MY WORKSTATIONIIS. Robben, Maastricht/NL; I. Apine, Riga/LV

ET 18
Auditorium VIII
#LVL
Imaging chronic mesenteric ischemia: the newII
UEG guideline

09:00	New insights on pathology
F. Carneiro, Porto/PT
09:20	Conventional imaging for staging and assessing
response
M. Rengo, Rome/IT
09:40	The role of functional and hybrid imaging
V. Vandecaveye, Leuven/BE
10:00 Case-based discussion

M. Mazzei, Siena/IT; C.J. Zech, Basel/CH

09:00 – 10:30 / Lecture Session
ET 19
Room 5A
Spleen: challenging cases #FROM MY WORKSTATION #LVL
A.J. Madureira, Porto/PT; C. Reiner, Zurich/CH

II

08:00 – 08:45 / Ultrasound Village
USV 7
Keynote Lecture
08:00	Welcome and introduction to the US Village
M. Ramalho, Almada/PT
08:05	Abdominal US: tips and tricks
J.B.C.M. Puylaert, The Hague/NL

30

LS 6
Auditorium VI#LVL
How non-invasive tests are used for theIIevaluation of chronic liver disease: guidelines
and beyond
Moderators: M. França, Porto/PT; L. Martí-Bonmatí, Valencia/ES

Room 5C

09:00	Summary of the 2021 EASL guidelines
V. Vilgrain, Clichy/FR
09:20	Role of Ultrasound in assessing steatosis and liver
fibrosis
M. Radzina, Riga/LV
09:40	Role of MRI in assessing steatosis and liver fibrosis
I. İdilman, Ankara/TR
10:00 Case-based discussion

THURSDAY, JUNE 2, 2022
09:00 – 09:45 / ESGAR Tutorials
ET 20
PET/MRI: ready for clinical practice?

Auditorium II
#LVL

II

O. Catalano, Boston, MA/US

10:00 – 10:45 / ESGAR Tutorials
ET 21
GEP-NET: challenging cases

Auditorium II
#LVL

II

#FROM MY WORKSTATION

G. Karmazanovsky, Moscow/RU; C. Schmid-Tannwald, Munich/DE

09:00 – 10:30 / Scientific Session
SS 5Interventional radiology

Auditorium III

Moderators: C.J. Zech, Basel/CH; E.-J. Vonken, Utrecht/NL
09:00	SS 5.2 Radiofrequency ablation of HCC: CT
texture analysis of the ablated area to predict
local recurrence
D. Autelitano, L. Geraci, L. Tomaiuolo, C. Longo,
M. Todesco, A. Carli, R. De Robertis, M. D‘Onofrio; Verona/IT
09:08	SS 5.3 Prospective assessment of liver healthfollowing liver resection and yttrium-90
radioembolization in patients with hepatocellular
carcinoma using multi-parametric MRI platform
M. Pansini1, J. Connell1, A. Fichera1, L. Nuñez1, E. Pickels1,
D.C. Ng2, A. Gogna2, B. Goh2, D. Wai Meng Tai2,
H. Chong Toh2, S.P. Choo2, W.Y. Chan2, T. Priyanthi2,
I.B. Tan2, R.H. Lo2, S.X. Yan2, C. Chua2, S.L. Koo2,
K.H. Lim2, J.A. Latiff2, H.S. Chua2, T.H. Choon2, R. Banerjee2,
M. Brady1, M. Kelly1, P. Chow2; 1Oxford/UK, 2Singapore/SG
09:16	SS 5.4 Safety and efficacy of hepatic intra-arterial
treatments in patients contraindicated for hepatectomy
after portal vein embolization
R. Bacquet1, M. Dioguardi Burgio2, L. Raynaud1, L. Paulatto3,
A. Sibert1, L. Garzelli1, J. Gregory1, J.-C. Bijot1, A. Chouard1,
V. Vilgrain1, M. Ronot1; 1Clichy/FR, 2Paris/FR, 3Montreuil/FR
09:24	SS 5.6 Percutaneous management of benign
biliary strictures after liver transplantation inpediatric patients: a single-center experience
L. Dulcetta1, P. Marra1, F. Carbone1, R. Muglia1,
P.A. Bonaffini1, S. Sironi2; 1Bergamo/IT, 2Milan/IT

09:32	SS 5.7 To retrospectively report 10-year experiencein diagnostic and interventional imaging versus
conservative management of pediatric acquired
arterioportal fistulas
B. Di Fazio, P. Marra, F. Carbone, L. Dulcetta, P.A. Bonaffini,
S. Sironi; Bergamo/IT
09:40	SS 5.8 Percutaneous stenting of malignant biliary hilar
obstructions using the moving cell stent: a singlecenter experience
F. Cortese, F. Acquafredda, A. Mardighian, M.T. Zurlo,
M. Conticchio, R. Memeo, R. Inchingolo;
Acquaviva delle Fonti/IT
09:48	SS 5.9 Analysis of postpancreatectomy
hemorrhage outcomes after interventional
radiology treatment
F. Mambrin, H. Nguyen, C. Gasparini, A. Contro,
G. Mansueto, R. De Robertis Lombardi; Verona/IT
09:56	SS 5.10 Completeness of reporting in abstracts ofpublished liver interventional radiology randomized
controlled trials
J. Gregory1, I. Boutron2, V. Vilgrain1, M. Ronot1; 1Clichy/FR,
2
Paris/FR

09:00 – 10:30 / Scientific Session
SS 6
Bowel inflammation

Auditorium VIII

Moderators: J. Brito, Faro/PT; K. De Paepe, Cambridge/UK
09:00	SS 6.1 Diagnostic performance of magnetic
resonance enterography disease activity
indices compared with a histological reference
standard for adult Crohn’s disease: experiencefrom the METRIC trial
S. Kumar, T. Parry, S. Mallett, G. Bhatnagar, A. Plumb,
S. Halligan, S. Taylor, . METRIC study Investigators;
London/UK
09:08	SS 6.2 Diagnostic performance of apparent diffusion
coefficient to assess therapeutic response to biologicaltherapy in Crohn’s disease
J. Rimola1, N. Capozzi2, A. Fernandez-Clotet1,
S. Rodriguez1, B. Caballol1, I. Ordás1, J. Panes1;
1
Barcelona/ES, 2Bologna/IT
09:16	SS 6.4 MR elastography of the ileocecal mesentery in
Crohn’s disease
K.J. Beek, N.P. Wassenaar, A.-S. van Schelt, J. Runge,
J. Stoker; Amsterdam/NL

31

THURSDAY, JUNE 2, 2022
09:24	SS 6.5 Crohn‘s disease: evaluation of intestinal fibrosis
by fibroblast-activating protein inhibitor-PET-MRenterography
M. Scharitzer, A. Beer, T. Mang, A. Haug, L.W. Unger,
W. Reinisch, M. Weber, L. Nics, T. Nakuz, M. Hacker,
M. Bergmann, S. Rasul; Vienna/AT
09:32	SS 6.6 Untangling and segmenting the small intestinein 3D cine-MRI using deep learning
L.D. van Harten, C.S. de Jonge, K.J. Beek, I. Išgum,J. Stoker; Amsterdam/NL
09:40	SS 6.7 Comparative evaluation of perianal fistula by
MR sequences with surgical reference
H. Özen Atalay, L. Soydan; Istanbul/TR
09:48	SS 6.8 Interobserver agreement of MAGNIFI-CD index
and radiological visual analogue scale of diseaseactivity in patients with perianal fistulizing Crohn’sdisease
K.J. Beek, L. Mulders, K. Horsthuis, J. Tielbeek, C. Buskens,
K. Gecse, G.R. D‘Haens, J. Stoker; Amsterdam/NL
09:56	SS 6.9 Bowel involvement is related to systemic
inflammatory response in COVID-19 patients
N. Chaniotaki, K. Dionysopoulos, G. Schinas, P. Zampakis,
M. Marangos, K. Akinosoglou, C. Kalogeropoulou;
Patras/GR

11:00 – 12:30 / Image Guided Therapy

11:00 – 12:30 / School of ESGAR

11:00 – 12:30 / Scientific Session

SOE 3
Auditorium I#LVL
Acute abdomen: a pain in the pancreas!

SS 7
Pancreas

Moderators: M.A. Bali, Brussels/BE; P. Boraschi, Pisa/IT

Moderators: J. Hermans, Nijmegen/NL; G. Zamboni, Verona/IT

11:00	‘Hot’ pancreas – where to begin?
T. Bollen, Nieuwegein/NL
11:30	‘Cold’ pancreas – where to begin?
M. Pezzullo, Brussels/BE
12:00 Case-based discussion

32

II

IGT 2
Auditorium VI#LVL
HCC – Role of radiology for diagnosis andIItreatment
Moderators: V. Vilgrain, Clichy/FR; A. Forner, Barcelona/ES
11:00	Staging of HCC with LI-RADS and the BCLC Treatment
Algorithm
C. Ayuso, Barcelona/ES
11:20	Classical HCC IR toolbox
T. Helmberger, Munich/DE
11:40	New systemic treatments and how they may interact
with IR
L. Tselikas, Villejuif/FR
12:00 Case-based discussion

11:00 – 12:00 / ESGAR Tutorials
ET 22
Auditorium II#LVL
Anatomical variants of the hepatic vessels andIIbile ducts: implications for surgery
M. Karçaaltıncaba, Ankara/TR; G. Morana, Treviso/IT

Auditorium III

11:00	SS 7.1 Arterial bleeding complicating acute necrotizing
pancreatitis: risk factors and predictive features
A. Guilloux, M. Ronot, A. Jemal Turki, I. Bouktif,
M. Gasperment, P. Levy, L. de Mestier, F. Maire, B. Jais,
V. Rebours, D. Lorenzo; Clichy/FR
11:08	SS 7.2 Fat stranding in acute pancreatitis can be amarker of severity. Is it influenced by the fat content
of the body?
N. Faluhelyi, U. Straube, R. Pilisi, P. Bogner; Pecs/HU
11:16	SS 7.3 Can preoperative CT scan and bioimpedance
vector analysis help to predict the development of
postoperative pancreatic fistula?
C. Maino1, T. Giandola2, M. Ragusi2, R. Corso2,
C. Talei Franzesi1; 1Milan/IT, 2Monza/IT

THURSDAY, JUNE 2, 2022
11:24	SS 7.4 Quantitative imaging analysis predicts
pancreatic fatty infiltration on routine CT
C. Previtali1, R. Sartoris2, M. Dioguardi Burgio1,
A. Couvelard2, V. Rebours2, A. Sauvanet2, V. Vilgrain2,
M. Ronot2; 1Paris/FR, 2Clichy/FR
11:32	SS 7.5 Histopathologic correlation of magnetic
resonance T1 signal intensity and enhancement ratioof pancreas with pancreatic fibrosis: comparison with
Cambridge Classification
T. Tirkes, O. Saeed, V. Osuji, C. Kranz, A. A. Roth,N. Zyromski, E. Fogel; Indianapolis, IN/US
11:40	SS 7.6 High prevalence of multi-organ steatosis andfibroinflammation, identified by multiparametricmagnetic resonance imaging, in people with type 2
diabetesN. Eichert1, K. Gibbons1, A. Hamid2, R. Ramkhelawon3,
J. Woolgar1, R. Suriano1, M. Pansini1, H. Thomaides-Brears1,
R. Banerjee1, G. Kemp1, S. Ali3, G. Thanabalasingham1,
D.J. Cuthbertson1; 1Oxford/UK, 2Liverpool/UK, 3London/UK
11:48	SS 7.7 Breathing task paradigm to improve the qualityof pancreatic magnetic resonance elastography
N.P. Wassenaar1, A.-S. van Schelt1, E.M. Schrauben1,
R. van der Woude1, J.E. de Jong1, J.L. Nelissen1,
H.W. van Laarhoven1, J. Guo2, I. Sack2, J. Runge1,
A.J. Nederveen1, J. Stoker1; 1Amsterdam/NL, 2Berlin/DE
11:56	SS 7.8 Feasibility of compressed sensing accelerated
Ristretto magnetic resonance elastography in thepancreas
A.-S. van Schelt1, N.P. Wassenaar1, J. Runge1, M. Troelstra2,
J.L. Nelissen1, C. Guenthner3, R. Sinkus4, J. Stoker1,
A.J. Nederveen1, E.M. Schrauben1; 1Amsterdam/NL,
2
London/UK, 3Zurich/CH, 4Paris/FR
12:04	SS 7.9 Abdominal imaging manifestations in COVID-19
and mucormycosis superinfection: experience from atertiary care hospital in India
H. Goyal, B. Sureka, P. Khera, P. Garg, T. Yadav, S. Tiwari,
A. Agarwal, V. Varshney, R. Rajagopal, M. K. Garg,
M. Banerjee, N. Kothari, A. Agarwal, G. Choudhary;
Jodhpur/IN
12:12	SS 7.10 The relationship of pancreatic and hepatic
steatosis assessed on CT with COVID-19 pneumonia
severity score and prognosis
H. Dogan1, E. Uzer1, O.T. Esengur1, H. Hassoy2, S. Guneyli2;
1Istanbul/TR, 2Izmir/TR

11:00 – 12:30 / Scientific Session
SS 8
Biliary tract/NET

Auditorium VIII

Moderators: B. Op De Beeck, Edegem/BE; L. Grazioli, Brescia/IT
11:00	SS 8.2 Simple diagnosis of relevant strictures inprimary sclerosing cholangitis patients using gadoxetic
acid-enhanced MRI
S. Pötter-Lang, N. Bastati-Huber, A. Messner, A. Kristic,
R. Ambros, A. Ba-Ssalamah; Vienna/AT
11:08	SS 8.3 Development and assessment of prognostic
value and agreement of a novel MRCP score forpatients with primary sclerosing cholangitis
A. Grigoriadis1, K.I. Ringe2, J. Bengtsson3, E. Baubeta-Fridh3,
C. Forsman4, N. Korsavidou-Hult4, F. Rorsman4, E. Nilsson3,
A. Bergquist1, N. Kartalis1; 1Stockholm/SE, 2Hannover/DE,
3
Lund/SE, 4Uppsala/SE
11:16	SS 8.4 Changes in ductal disease captured
by quantitative magnetic resonancecholangiopancreatography in primary sclerosing
cholangitis
P.J. Trivedi1, K. Arndtz1, N. Abbas1, M. Pansini2, A. Telford2,
L. Young2, C. Ferreira3, R. Banerjee2, P. Eddowe4,
K.S. Jhaveri5, G.M. Hirschfield5; 1Birmingham/UK,
2
Oxford/UK, 3Aveiro/PT, 4Nottingham/UK, 5Toronto, ON/CA
11:24	SS 8.5 Prediction of intracholecystic papillary
neoplasm with associated invasive carcinoma of thegallbladder using preoperative contrast-enhanced
computed tomography and ultrasound
J.H. Kim, H.-J. Kang, J. Bae, J.H. Kim; Seoul/KR
11:32	SS 8.6 Metastatic pattern of carcinoma gallbladder on
abdominal CT scan and its prognostic impact
G.R. Agarwal, Y. Gupta, N. Singh, S. Narayan, R. Yagnik,
A. Gandhi, G. Gupta, P. Singh; Lucknow/IN
11:40	SS 8.7 Changes in volumetric enhancing tumor burden
on CT predicts survival outcomes in patients withneuroendocrine liver metastases after intra-arterial
treatments
J. Assouline1, R. Cannella2, G. Porrello2, L. de Louis1,
M. Dioguardi Burgio3, M.-P. Vullierme1, O. Hentic1,
V. Vilgrain1, R. Duran4, M. Ronot1; 1Clichy/FR, 2Palermo/IT,
3
Paris/FR, 4Lausanne/CH

33

THURSDAY, JUNE 2, 2022
11:48	SS 8.9 CT texture end contrast enhancement featuresin preoperative pancreatic neuroendocrine tumors
prediction
I. Gruzdev, V. Tikhonova, K. Zamyatina, V. Struchkov,
E. Kondratyev, G. Karmazanovsky; Moscow/RU
11:56	SS 8.10 Treatment assessment of PNET
and NELM after everolimus by quantitative
MRI parameters
M.K. Ingenerf, J. Ricke, C. Auernhammer, S. Kiesl,
J. Rübenthaler, F. Berger, C. Schmid-Tannwald; Munich/DE

12:45 – 13:45 / Industry Symposium
SY 4
Industry-sponsored Symposium

Auditorium I

For details please refer to page 67.

12:45 – 13:30 / Tricky Cases
TC 2
Tricky cases from my day job

Auditorium II

Moderators: C. Reiner, Zurich/CH; K. De Paepe, Cambridge/UK

11:00 – 11:45 / ESGAR Tutorials
ET 23
CT colonography difficult cases#FROM MY WORKSTATION

Room 5A#LVL

IIT. Mang, Vienna/AT; P. Lefere, Roeselaere/BE

12:00 – 12:45 / ESGAR Tutorials
ET 24
Room 5A#LVL
Vascular and biliary complications after liverII
transplant #SINGLE TOPIC

12:45	What‘s going on in the pancreas?
P. Rodríguez Carnero, Madrid/ES
12:54	Do not forget the basics
C. Maino, Milan/IT
13:03	A different cyst
B. Rea, Sheffield/UK
13:12	Motor vehicle injury
M. Duczkowska, Szczecin/PL
13:21	Look for details: tricky biliary case!
F. Castagnoli, Brescia/IT

A. Perez-Girbes, Valencia/ES; A. Samuilis, Vilnius/LT

12:45 – 13:45 / Research Tutorials

11:00 – 11:30 / Ultrasound Village

RT 2
Auditorium III#LVL
Reading another AI paper? – what to reallyIIlook for

USV 9
Room 5C
US of the abdomen: Live demo on large screen

Moderators: M. Maas, Amsterdam/NL; I. Santiago, Lisbon/PT

J.B.C.M. Puylaert, The Hague/NL

12:45	Reading another AI paper? – what to really look for
N. Papanikolaou, Lisbon/PT
13:25 Questions and answers

11:30 – 12:30 / Ultrasound Village
14:00 – 15:30 / Ultrasound Village
USV 10
Room 5C
Abdominal US Hands-on training (5 US machines, 5models, 5 tutors)
Tutors:J.B.C.M. Puylaert, The Hague/NL
I. Vanhooymissen, The Hague/NL
M. Scheurkogel, The Hague/NL
S. Robben, Maastricht/NL
E. Coerkamp, The Hague/NL

34

USV 11
Keynote Lectures
14:00	US of acute paediatric abdomen
S. Robben, Maastricht/NL
14:45	US of acute urological abdomen
I. Vanhooymissen, The Hague/NL

Room 5C

THURSDAY, JUNE 2, 2022
14:30 – 16:00 / Lecture Session
LS 7
In and around the duodenum

14:30 – 16:00 / Scientific Session
Auditorium I

Moderators: A. Torregrosa Andrés, Valencia/ES;
D. Ippolito, Monza/IT

#LVL

II

14:30	Unique pathology of this bowel segment
D. Ramos Andrade, Coimbra/PT
14:50	Other benign conditions
A.R. Radmard, Tehran/IR
15:10	Malignant tumours
R. Cannella, Palermo/IT
15:30 Case-based discussion

14:30 – 16:00 / Lecture Session
LS 8
Auditorium VI#LVL
Tumour response in abdominal imaging:II
how to appraise?
Moderators: V. Herédia, Evora/PT; E. Chartampilas, Thessaloniki/GR
14:30	Colorectal liver metastases
W. Schima, Vienna/AT
14:50	Pancreatic cancer
E. Soloff, Seattle, WA/US
15:10	GIST
D. Regge, Turin/IT
15:30 Case-based discussion

14:30 – 15:15 / ESGAR Tutorials
ET 25
Auditorium II
Optimising your CT technique in acute abdomen: #LVL
II
the ESGAR/ESUR guideline
M. Zins, Paris/FR; I. Millet, Montpellier/FR

15:30 – 16:15 / ESGAR Tutorials
ET 26
Auditorium II
New insights on imaging and management of#LVL
IIgallbladder polyps: the ESGAR guideline

SS 9
Small bowel and colon

Auditorium III

Moderators: M. Ronot, Clichy/FR; P. Rodríguez Carnero, Madrid/ES
14:30	SS 9.1 Factors predicting transmural necrosis inpatients with acute mesenteric venous thrombosis
F. Salahshour1, E. Shaker1, A. Abkhoo1, F. Shojaeshafiei2,
N. Ayoobi Yazdi1; 1Tehran/IR, 2Ramsar/IR
14:38	SS 9.2 Acute mesenteric ischemia: diagnostic value of
QT parameters and their relationship with CT findings
B. Alan, S. Gurel, S. Alan; Bolu/TR
14:46	SS 9.3 Are qualitative and quantitative CT parameters
prognostic in non-occlusive mesenteric ischemia?
B. Alan, S. Gurel; Bolu/TR
14:54	SS 9.4 Reperfusion injury on computed tomography
following endovascular revascularization of early acutemesenteric ischemia: incidence, risks factors andoutcomeL. Garzelli1, A. Nuzzo1, A. Hamon1, I. Ben Abdallah2,
L. Paulatto1, L. Raynaud1, Y. Castier2, Y. Panis1, O. Corcos1,
V. Vilgrain1, M. Ronot1; 1Clichy/FR, 2Paris/FR
15:02	SS 9.5 Beyond chest: ischemic and hemorrhagic
complications of the abdomen in COVID-19 patients
P.N. Franco1, P. Bonaffini1, A. Bonanomi1, C. Valle1,
P. Marra1, S. Sironi2; 1Bergamo/IT, 2Milan/IT
15:10	SS 9.6 Endovascular thrombectomy for therevascularization of acute occlusive arterial
mesenteric ischemia: no benefit of mechanical overmanual thrombectomy
L. Garzelli1, I. Ben Abdallah2, A. Nuzzo1, J. Gregory1,
L. Paulatto1, J.-C. Bijot1, L. Raynaud1, M. Dioguardi Burgio2,
V. Vilgrain1, O. Corcos1, Y. Castier2, M. Ronot1; 1Clichy/FR,
2
Paris/FR
15:18	SS 9.8 Added value of positive intraluminal contrast
CT over fluoroscopic examination for detecting
gastrointestinal leakage after gastrointestinal surgery
S.H. Kim, M.G. Kim, S.K. Jeon, S. Han; Seoul/KR
15:26	SS 9.9 Correlation of CT radiomic featuresfor GISTs with the pathological classificationand molecular subtypes: preliminary andmonocentric experience
D. Palatresi, F. Fedeli, G. Danti, G. Grazzini, S. Pradella,
V. Miele; Florence/IT#SINGLE TOPIC

K. Foley, Cardiff/UK; M. Lahaye, Amsterdam/NL

35

THURSDAY, JUNE 2, 2022
15:34	SS 9.10 Reclassifying abdominal non-uterine
leiomyosarcoma: using a radiological anatomic
approach with implications for patient outcomes
U. Tarique1, D. Cyr1, C. Morosi2, G. Greco2, B. Dickson1, R.
Gladdy1, D. Collegaro2, A. Gronchi2, C. Swallow1, K. Khalili1;
1
Toronto, ON/CA, 2Milan/IT

16:30 – 17:00 / Honorary Lecture
HL 3
SAR Honorary Lecture

Auditorium I

Moderator: A. Laghi, Rome/IT
Imaging evaluation before surgical resection
K.M. Elsayes, Houston, TX/US

14:30 – 16:00 / School of ESGAR
SOE 4
Hot livers and gallbladders

Auditorium VIII

Moderators: S. Sen, Kolkata/IN; M. Özmen, Ankara/TR

II

14:30	Cholecystitis and mimickers
D. Veiga Canuto, Valencia/ES
15:00	Is it a liver abscess?
A. Luciani, Créteil/FR
15:30 Case-based discussion

15:30 – 16:30 / Ultrasound Village
USV 12
Room 5C
Abdominal US Hands-on training (5 US machines,
5 models, 5 tutors)
Tutors:J.B.C.M. Puylaert, The Hague/NL
I. Vanhooymissen, The Hague/NL
M. Scheurkogel, The Hague/NL
S. Robben, Maastricht/NL
E. Coerkamp, The Hague/NL

36

17:00 – 18:00 / Plenary Session

#LVL

PS 3
Auditorium I#LVL
Clinical Files Session: live interpretation ofIIabdominal cases
Moderator: G. Brancatelli, Palermo/IT
Panellists:
N. Bastati-Huber, Vienna/AT
K. Cortis, Msida/MT
R. Pozzi Mucelli, Stockholm/SE
F. Wessels, Utrecht/NL

PROGRAMME OVERVIEW – FRIDAY, JUNE 3, 2022
Auditorium I
08:00-08:30

ET 27

Intraductal papillary
mucinous neoplasmsof the pancreas

Auditorium VI
ET 28

AI for abdominal
radiologists: cases
from daily practice

08:30-09:00

09:00-09:30

09:30-10:00

LS 9
Spectrum of biliary
diseases: what is
new?

LS 10
It’s back: local recurrence
and regrowth incolorectal cancer

10:00-10:30

10:30-11:00

11:00-11:30

11:30-12:00

SOE 5
Postoperative imaging of the upper
abdomen

ET 35
Optimising reporting of cross-sectional imaging in
Crohn’s disease

Auditorium II
ET 29

Imaging post IR treatment of liver tumours– pearls and pitfalls

ET 33
Interactive cases
for aces: small
bowel and uterus

ET 34
Imaging complications of bariatricsurgery

IGT 3Acute abdominal
haemorrhage

Auditorium III
ET 30

Auditorium VIII
ET 31

Abdominal manifestations of Covid-19

MR Imaging offistula-in-ano

SS 10Hepatocellular
carcinoma/liverfunction

SS 11
Rectal cancer/
colorectal liver
metastases

SS 12
Peritoneum/
technique

Room 5A

Room 5C

ET 32

Current recommendations for abdominal imaging during pregnancy

USV 13
Keynote Lecture

ET 36
Autoimmune
pancreatitis

USV 14
Keynote Lecture

USV 15
Hands-on Training

12:00-12:30

12:30-13:00

13:00-13:30

Industry Symposium

RT 3
Writing the perfectpaper review

13:30-14:00

14:00-14:30

14:30-15:00

15:00-15:30

PS 4 & 5
Nick Gourtsoyiannis’ Foundation
Course – Rad-pathcorrelation

15:30-16:00

37

FRIDAY, JUNE 3, 2022
08:00 – 08:45 / ESGAR Tutorials

09:00 – 10:30 / Lecture Session

ET 27
Auditorium I
Intraductal papillary mucinous neoplasms of the #LVL
IIpancreas: the pandemic in the upper abdomen

LS 10
Auditorium VI#LVL
It’s back: local recurrence and regrowth inIIcolorectal cancer

C. Matos, Lisbon/PT; M. D’Onofrio, Verona/IT

Moderators: C. Hoeffel, Reims/FR; S. Rafaelsen, Vejle/DK

ET 28
Auditorium VI#LVL
AI for abdominal radiologists: cases from dailyIIpractice #FROM MY WORKSTATION

09:00	Clinical significance of local relapse after colorectal
cancer surgery
M. Gollub, New York, NY/US
09:20	Imaging of local recurrence after surgery
I. Santiago, Lisbon/PT
09:40	Regrowth during watch & wait
M. Maas, Amsterdam/NL
10:00 Case-based discussion

J. Van Griethuysen, Amsterdam/NL; N. Papanikolaou, Lisbon/PT

ET 29
Auditorium II#LVL
Imaging post IR treatment of liver tumours –IIpearls and pitfalls
S. Mulé, Crèteil/FR; M. Maurer, Bern/CH

ET 30
Auditorium III#LVL
Abdominal manifestations of Covid-19

09:00 – 09:45 / ESGAR Tutorials

D. Caruso, Rome/IT; A. Arjonilla, Madrid/ES

ET 33
Auditorium II#LVL
Interactive cases for aces: small bowelIIand uterus

ET 31
MR Imaging of fistula-in-ano

IIAuditorium VIII
#LVL

II

A. Negård, Lørenskog/NO; J. Stoker, Amsterdam/NL

ET 32
Current recommendations for abdominal
imaging during pregnancy

Room 5A

C. Menias, Phoenix, AZ/US; M.M. Otero-García, Vigo/ES

10:00 – 10:45 / ESGAR Tutorials

#LVL

II

C. Bourgioti, Athens/GR; R. Wiles, Liverpool/UK

ET 34
Auditorium II#LVL
Imaging complications of bariatric surgery
D. Blunt, London/UK; M. Obmann, Basel/CH

II

09:00 – 10:30 / Lecture Session
09:00 – 10:30 / Scientific Session
LS 9
Auditorium I#LVLSpectrum of biliary diseases: what is new?
Moderators: J.M. Lee, Seoul/KR; L. Grazioli, Brescia/IT
09:00	Primary and secondary cholangitis: tips fordifferentiation
M.A. Bali, Brussels/BE
09:15	Pre-neoplastic biliary lesion: intraductal papillarybiliary neoplasm
B. Henninger, Innsbruck/AT
09:30	Intrahepatic cholangiocarcinoma: update
J.H. Yoon, Seoul/KR
09:45 Case-based discussion

38

II

SS 10
Auditorium III
Hepatocellular carcinoma/liver function
Moderators: B. Van Beers, Clichy/FR; A. Torregrosa Andrés,Valencia/ES
09:00	SS 10.1 Sarcopenia impairs survival and treatment
efficacy in patients with hepatocellular carcinoma
undergoing immunotherapy
K. Lampichler, K. Pomej, L. Beer, L. Balcar, T. Meischl,
C. Müller, M. Trauner, M. Scharitzer, D. Tamandl,
B. Scheiner, M. Pinter; Vienna/AT

FRIDAY, JUNE 3, 2022
09:08	SS 10.2 Prognostic values of LI-RADS categories vs.
histopathological features in patients with solitary HCC
undergoing hepatic resection: a multicentric study
F. Matteini1, R. Cannella1, R. Sartoris2, M. Dioguardi Burgio3,
S. Mulé4, M. Wagner3, J.-C. Nault5, F. Cauchy3, O. Scatton3,
A. Laurent4, O. Seror5, A. Luciani4, V. Vilgrain2, M. Ronot2;
1
Palermo/IT, 2Clichy/FR, 3Paris/FR, 4Créteil/FR, 5Bobigny/FR
09:16	SS 10.3 Hepatocellular carcinoma treated bystereotactic ablative radiotherapy: response
assessment and imaging features on MRI
C. Corallo, A. Littlejohns, C. Podesta, R. Goody,
N. Casanova, A. Scarsbrook, R. Albazaz; Leeds/UK
09:24	SS 10.4 Can CT perfusion imaging predict tumor
response to antiangiogenetic treatment in HCC
patients?
C. Maino, M. Ragusi, T. Giandola, R. Corso, C. Talei
Franzesi; Monza/IT
09:32	SS 10.5 Hepatocellular carcinoma in patients with
non-alcoholic steatoheaptitis is associated withheterogeneous pattern of fat infiltration in skeletal
muscles
M. Nachit1, M. Dioguardi Burgio2, A. Abyzov2, P. Garteiser2,
V. Paradis3, V. Vilgrain3, I. Leclercq1, B. Van Beers3;
1Brussels/BE, 2Paris/FR, 3Clichy/FR
09:40	SS 10.6 Combined functional liver imaging scorederived from gadoxetic acid-enhanced MRI andspleen size as predictors of mortality and hepatic
decompensation in chronic liver disease
N. Bastati-Huber, L. Beer, S. Pötter-Lang, T. Reiberger,
M. Mandorfer, A. Ba-Ssalamah; Vienna/AT
09:48	SS 10.7 Automated liver segmental volume ratio
quantification on non-contrast T1–VIBE Dixon liver MRI
using an artificial neural network
L. Zbinden1, D. Catucci2, Y. Suter1, A. Berzigotti1, L. Ebner1,
A. Christe1, V. Obmann1, R. Sznitman1, A. Huber1; 1Bern/CH,
2
Herrenschwanden/CH
09:56	SS 10.8 CT-based volumetry as complement to liver
scintigraphy for the follow-up of auxiliary partial
orthotopic liver transplantation
A. Kirchner1, M. Ronot1, F. Dondero1, F. Durand1,
M. Lesurtel1, R. Lebtahi1, V. Vilgrain1, M. Dioguardi Burgio2;
1
Clichy/FR, 2Paris/FR
10:04	SS 10.9 Evaluation of liver injury with MRI after
chemotherapy
L. Tomaiuolo, L. Geraci, C. Longo, M. Todesco,
D. Autelitano, A. Carli, F. Cicalo‘, F. Moro, R. De Robertis,
N. Cardobi, M. D‘Onofrio; Verona/IT

10:12	SS 10.10 Quantitative ΜRI in the evaluation of patientswith non-alcoholic steatohepatitis
F. Pucciarelli, M. Zerunian, M. Polici, B. Masci, E. Iannicelli,
D. Caruso, A. Laghi; Rome/IT

09:00 – 10:30 / Scientific Session
SS 11
Auditorium VIII
Rectal cancer/colorectal liver metastases
Moderators: R. Basilico, Chieti/IT; W. Schima, Vienna/AT
09:00	SS 11.1 Multireader comparison and validation ofpreviously published MRI tumour response evaluation
methods in rectal cancer
N. El Khababi1, M.J. Lahaye1, M. Maas1, S. Nougaret2,
L. Curvo-Semedo3, R. Tissier1, N. Bogveradze4,
N.W. Schurink1, J. van Griethuysen1, R.G.H. Beets-Tan1,
D. Lambregts1, +. Multicenter MRI rectal study group1;
1
Amsterdam/NL, 2Montpellier/FR, 3Coimbra/PT, 4Tbilisi/GE
09:08	SS 11.2 Impact of MR image quality on
diagnostic performance to assess response after
chemoradiotherapy in rectal cancer
N. El Khababi1, M. Maas1, M.J. Lahaye1, S. Nougaret2,
L. Curvo-Semedo3, R. Tissier1, N. Bogveradze4,
N.W. Schurink1, J. van Griethuysen1, R.G.H. Beets-Tan1,
D. Lambregts1, +. Multicenter MRI rectal study group1;
1
Amsterdam/NL, 2Montpellier/FR, 3Coimbra/PT, 4Tbilisi/GE
09:16	SS 11.3 Predicting response to chemoradiotherapy
in rectal cancer via visual assessment on baseline
staging MRI: a multicenter and multireader study
N. El Khababi1, M.J. Lahaye1, M. Maas1, S. Nougaret2,
L. Curvo-Semedo3, N. Bogveradze4, N.W. Schurink1,
J. van Griethuysen1, R.G.H. Beets-Tan1, D. Lambregts1,+. Multicenter MRI rectal study group1; 1Amsterdam/NL,
2
Montpellier/FR, 3Coimbra/PT, 4Tbilisi/GE
09:24	SS 11.4 The definition of a near-complete response
after neoadjuvant (chemo)radiotherapy for rectal
cancer: results of an expert survey
P. Custers, G.L. Beets, D. van der Reijd, M. van Leerdam,
B. van Triest, D. Lambregts, M. Maas; Amsterdam/NL

39

HEADLINEFRIDAY,JUNE 3, 2022
09:32	SS 11.8 Impact of liver MRI in addition to CT
on the local treatment plan of patients withcolorectal liver metastases: a systematic review
and meta-analysis
B. Görgec1, I.M. Verpalen1, M. Abu Hilal1, S. Bipat1,
C. Verhoef2, R.J. Swijnenburg1, M. Besselink1, J. Stoker1;
1
Amsterdam/NL, 2Rotterdam/NL
09:40	SS 11.9 Imaging characteristics of colorectal
liver metastases before and after chemotherapy
on gadoxetic acid-enhanced MRI
D. Van der Reijd, E. Soykan, B. Heeres, D. Lambregts,
T. Buffart, K. Kuhlmann, R.G.H. Beets-Tan, M. Maas,
E. Klompenhouwer; Amsterdam/NL
09:48	SS 11.10 External validation of a CT-based radiomics
model for the prediction of local tumour progression
after ablation in colorectal liver metastases
D. Van der Reijd1, F. Staal1, C. Guerendel1, M. Busard1,
S. Benson1, M. Taghavi1, S. Roberti1, E. Klompenhouwer1,
A. Moelker2, C. Verhoef2, M. Starmans2, R.G.H. Beets-Tan1,
M. Maas1; 1Amsterdam/NL, 2Rotterdam/NL

09:25 – 10:15 / Ultrasound Village
USV 13
Keynote Lecture

11:00 – 12:00 / ESGAR Tutorials
ET 35
Auditorium VI
Optimising reporting of cross-sectional imaging #LVL
IIin Crohn’s disease: the ECCO ESGAR Topical
Review
J. Rimola, Barcelona/ES; J. Tielbeek, Amsterdam/NL

11:00 – 12:30 / Image Guided Therapy
IGT 3
Acute abdominal haemorrhage

Auditorium II#LVLModerators: O. Akhan, Ankara/TR; R. Lukšaitė, Vilnius/LT

II

11:00	Detection of haemorrhage – protocols that work
S. Schindera, Aarau/CH
11:15	Variceal upper GI haemorrhage
A. Denys, Lausanne/CH
11:30	Non-variceal upper GI haemorrhage
R. Loffroy, Dijon/FR
11:45	Non-traumatic haemorrhage in liver
C. Stroszczynski, Regensburg/DE
12:00 Panel discussion

Room 5C
11:00 – 12:30 / Scientific Session

09:25	Welcome and introduction to the US Village
J.B.C.M. Puylaert, The Hague/NL

SS 12
Peritoneum/technique

09:30 	US of acute abdomen: RUQ
E. Coerkamp, The Hague/NL

Moderators: V. Vandecaveye, Leuven/BE; S. Pötter-Lang, Vienna/AT

11:00 – 12:30 / School of ESGAR
SOE 5
Auditorium I#LVL
Postoperative imaging of the upper abdomen
Moderators: T. Lauenstein, Düsseldorf/DE; A. Negård,Lørenskog/NO
11:00	Postoperative imaging of the liver
V. Obmann, Bern/CH
11:30	Postoperative imaging of the pancreas
R. Fischbach, Hamburg/DE
12:00 Case-based discussion

40

Auditorium III

II

11:00	SS 12.1 The value of providing a second readof external imaging for patients referred to a
specialist peritoneal malignancy centre
J. El-Sheikha, A. Bhagwanani, O. Duxbury, D. Patel, N. Shah,
A. Thrower; Basingstoke/UK
11:08	SS 12.2 FDG-PET/MRI for the preoperative diagnosis
and staging of peritoneal carcinomatosis: aprospective multireader pilot study
N. Vietti Violi1, S. Gavane2, P. Argiriadi2, A. Law2, S. Heiba2,
M. Ghesani2, E. Bekhor3, J. Babb2, D. Labow2, B. Taouli2;
1
Lausanne/CH, 2New York, NY/US, 3Petah Tikva/IL
11:16	SS 12.3 Dual-energy CT for the identification andquantification of peritoneal metastases: stepping
forward CT contrast resolution
G. Bagnacci, S. Guerrini, F. Gentili, L. Volterrani, M. Mazzei,
L. Sansotta, I. Monteleone; Siena/IT

FRIDAY, JUNE 3, 2022
11:24	SS 12.4 Deep-learning image reconstruction for
low-dose liver CT
A. Del Gaudio, G. Guido, D. Caruso, N. Ubaldi,
D. Valanzuolo, G. Bona, D. Pugliese, A. Laghi; Rome/IT
11:32	SS 12.5 Are dilution and slow injection withfluoroscopic triggering technique the solution
to mitigating arterial-phase artifacts ingadoxetic acid-enhanced liver MRI?
R. Ambros, S. Pötter-Lang, A. Messner, A. Kristic,
J.C. Hodge, N. Bastati-Huber, A. Ba-Ssalamah; Vienna/AT
11:40	SS 12.6 Reduction of contrast agent volume andradiation dose in pancreatic dynamic CT by a
combination of 90KVP tube voltage, high tube
current modulation, and advanced iterative
reconstruction algorithm
M.S. Park, H.I. Ha, J.-H. Ahn; Anyang-si/KR
11:48	SS 12.7 Comparison of CAIPIRINHA-VIBE andconventional-VIBE sequences in liver MRI
M. Orvieto, D. Urso, F. Crimì, E. Quaia, F. Vernuccio; Padua/IT
11:56	SS 12.8 Contribution of cine MRI sequences inlocal staging of esophageal cancer
L. Haefliger, M. Jreige, N. Villard, C. Du Pasquier,J.-B. Ledoux, N. Vietti Violi, C. Dromain; Lausanne/CH
12:04	SS 12.9 MR angiography with inflow-sensitive
inversion recovery technique for upper
abdominal arteries assessment: comparison
with contrast-enhanced MRI and CT angiography
C. Cazzella1, P. Bonaffini1, R. Simonini1, M. Porta2,
C. Maino3, L. Dulcetta1, F. Carbone1, P. Marra1, P. Brambilla1,
S. Sironi3; 1Bergamo/IT, 2Monza/IT, 3Milan/IT

11:45 – 12:45 / Ultrasound Village

11:00 – 11:45 / ESGAR Tutorials

14:00 – 15:00 / Plenary Session

ET 36
Room 5A
Autoimmune pancreatitis #FROM MY WORKSTATION #LVL

PS 4
Auditorium I#LVL
Nick Gourtsoyiannis’ Foundation Course 1 –II
Rad-path correlation: Pancreas

C. Triantopoulou, Athens/GR; C. Valls, Stockholm/SE

II

USV 15
Room 5C
Abdominal US Hands-on training (5 US machines,
5 models, 5 tutors)
Tutors:J.B.C.M. Puylaert, The Hague/NL
I. Vanhooymissen, The Hague/NL
S. Robben, Maastricht/NL
E. Coerkamp, The Hague/NL
W. Ibrahim, Jülich/DE

12:34 - 13_45 / Industry Symposium
SY 5
Industry-sponsored Symposium

Auditorium I

For details please refer to page 63.

12:45 – 13:45 / Research Tutorials
RT 3
Writing the perfect paper review

Auditorium III

Moderators: S.A. Taylor, London/UK; M. Ronot, Clichy/FR

#LVL

II

12:45	Writing the perfect paper review
Y. Menu, Paris/FR
13:25 Questions and answers

Moderators: A. Torregrosa Andrés, Valencia/ES; V. Vandecaveye,
Leuven/BE

11:00 – 11:45 / Ultrasound Village
USV 14
Keynote Lecture

Room 5C

14:00	Pancreatic cystic tumours
N. Kartalis, Stockholm/SE; R.C. Oliveira, Coimbra/PT
14:30	Non-adenocarcinoma pancreatic solid tumours
G. Zamboni, Verona/IT; R.C. Oliveira, Coimbra/PT

11:00	US of acute abdomen: RLQ
J.B.C.M. Puylaert, The Hague/NL

41

FRIDAY, JUNE 3, 2022
15:00 – 16:00 / Plenary Session
PS 5
Auditorium I#LVL
Nick Gourtsoyiannis’ Foundation Course 2 –IIRad-path correlation: GI tumours
Moderators: A. Torregrosa Andrés, Valencia/ES; V. Vandecaveye,
Leuven/BE
15:00	Non-adenocarcinoma gastric cancer
G. Tardáguila de la Fuente, Vigo/ES; S. Landolfi,
Barcelona/ES
15:30	Non-epithelial bowel tumours
D. Armario, Barcelona/ES; S. Landolfi, Barcelona/ES

42

SCIENTIFIC SESSIONS ON DEMAND
SSD 1
Miscellaneous
SSD 1.1	Safety of percutaneous, image-guided biopsyof hepatocellular carcinoma with and without
concurrent ablation
J. Tse1, K. Terashima2, L. Shen1, D. Lu3, S. Raman3;
1
Stanford, CA/US, 2San Francisco, CA/US,3
Los Angeles, CA/US
SSD 1.2	Growth kinetics of pancreatic neuroendocrine tumors
by histopathologic grade
J. Tse, L. Shen, A. Kamaya; Stanford, CA/US
SSD 1.3	Colonoscopy versus catheter angiography for lower
gastrointestinal bleeding following localization on CT
angiography
J. Tse1, E. Felker2, G. Tse2, T. Liang1, J. Shen1, A. Kamaya1;
1
Stanford, CA/US, 2Los Angeles, CA/US
SSD 1.4	Application of apparent diffusion coefficients derived
from intratumoral and peritumoral zone for assessing
pathologic prognostic factors in rectal cancer
H. Li, Y. Yuan, H. Pu; Chengdu/CN

On Demand

SSD 1.5	MRI assessment of rectal cancer response toneoadjuvant therapy: a multireader study
J.B. Yuval1, S. Patil1, N. Gangai1, D.G. Akselrod2, A. Fung3,
C.B. Harmath4, R. Kampalath5, K. Krehbiel6, S. Lee5,
P.S. Liu7, J.D. Millet8, R.B. O’Malley9, A.S. Purysko7,
J.C. Veniero7, A.P. Wasnik8, J. Garcia-Aguilar1,
M.J. Gollub1; 1New York, NY/US, 2Burlington, VT/US,
3
Portland, OR/US, 4Chicago, IL/US, 5Irvine, CA/US,
6
Omaha, NE/US, 7Cleveland, OH/US, 8Ann Arbor, MI/US,
9
Seattle, WA/US
SSD 1.6	CT with deep-learning denoising model inparticipants at high risk for HCC: prospective,
randomized, single-blinded preliminary study
H.-J. Kang, J.M. Lee, J.H. Kim, S. Han; Seoul/KR

43

ESGAR 2022
ONLINEDid you miss a session?
All content is available on the ESGAR 2022 Online Platform
until September 3, 2022.

44

POSTERPRESENTATIONSALL EDUCATIONAL / SCIENTIFIC EXHIBITS ARE DISPLAYEDIN THE EXHIBITION AREA ON THE LEVEL 1.
A NUMBER OF COMPUTER TERMINALS ARE AVAILABLE FOR
VIEWING THE PRESENTATIONS.
THE POSTERS ARE ACCESSIBLE ONLINE AS WELL:

POSTER PRESENTATIONS – EDUCATIONALPOSTER PRESENTATIONS – SCIENTIFIC

Magna Cum Laude

Cum LaudePage 46 – 51
Page 52 – 56

Certificate of Merit

Recommended Poster

45

POSTER PRESENTATION – EDUCATIONALHEADLINE
ABDOMINAL VASCULAR IMAGING
EE-001	A systematic guide to the diagnosis of portal vein
conditions: tips and pitfalls
G. Porrello, R. Cannella, G. Brancatelli; Palermo/IT
EE-002	Rex bypass imaging essentials
J. Facas, J. Costa, A. Agostinho, P. Donato; Coimbra/PT
EE-004	Abdominal vascular compression syndromes – From
CT to the other imaging techniques
V.F. Mendes1, R. Cordeiro2, J. Santos Silva1, T. Oliveira1,
A. Estevão1, P. Donato1; 1Coimbra/PT, 2Ponta Delgada/PT
EE-005	Portal hypertension: the radiological diagnosis
approach
J. Vieira, A. Pinto, A. Mesquita, P. Cordeiro;
Ponta Delgada/PT
EE-006	One angle, two syndromes: aortomesenteric angle
U. Gulturk, E. Hocaoglu, E. Inci; Istanbul/TR
EE-007	Imaging the inferior vena cava: a review of key MDCT
findings
O.-S. Garbea; Cluj Napoca/RO

ACUTE ABDOMEN
EE-008	Mind the bubbles: a case-based review ofemphysematous infections of the abdomen andpelvisP.M. Sousa, A. Primitivo, A.C. Ferreira; Loures/PT
EE-009	Acute appendicitis at the light of the Nijmegen
Consensus Conference
J.-P. Tasu, N. Beydoun, A. Guerrab, S. Velasco, G. Herpe;
Poitiers/FR
EE-010	Acute pancreatitis – Complications not to miss
A.Q. Fonseca, A.L. Proença; Lisbon/PT
EE-011	Intestinal volvulus: a potentially fatal twist
P. Carvalho Almeida, C. Casanova, R.G. Santos,
L. Amaral Ferreira, P. Donato; Coimbra/PT
EE-012	Acute right upper quadrant pain: imaging pitfalls
and pearls
D. Kotecha, M. Amir, J. Pancholi, K. Kim, V. Rudralingam;
Manchester/UK
EE-013	CT findings of complications from acutecholecystitis: a pictorial review
F. Sandomenico, E. Laverde, L. Sanduzzi, E. Vicenzo,
L. Pirolo, F.R. Setola, U. Dello Iacono, S. Maione,
V. Macchia, A. Brunetti; Naples/IT

46

EE-015	Pediatric abdominal trauma – Imaging and findings
R. Pina-Prata, A. Forjaco, P. Riesenberger, A. Nunes;
Lisbon/PT
EE-016	Ingested fishbone complications: what to look for ina CT scan
M.V. Dias, S. Teixeira, H. Gomes, J. Monteiro, D. Cardoso,
D. Silva; Viseu/PT
EE-017	Epiploic appendagitis, a rare cause of abdominal pain
M.V. Dias, S. Teixeira, H. Gomes, J. Monteiro, D. Cardoso,
D. Silva; Viseu/PT
EE-018	The mystical mesenteric arteries: unwinding themagic through a radiologist‘s perspective
P. Malik, P. Garg, T. Yadav, B. Sureka, P. Khera, S. Tiwari,
A. Hegde, S. Saxena; Jodhpur/IN
EE-019	Foreign body GI perforation – A bone to pick?
S. Patel, P. Brown, D. Murray, M. Steward, D. Sadigh,C.M. Onnie, H. Mukhtar; London/UK
EE-020	Imaging of acute mesenteric ischemia: a pictorial
review
J. Sousa, B. Giesteira, A. Alves, W. Schmitt; Porto/PT
EE-021	Acute low back pain (ALBP): a review of clinical andimaging features of main extra-axial causes
B. Di Fazio1, E. Piccin1, P.A. Bonaffini2, C. Valle1,
R. Cosentini1, S. Sironi1, C. Bandini1; 1Milan/IT,
2
Bergamo/IT
EE-023	Role of diagnostic and interventional radiology inacute abdominal conditions
S. Shikhare, S. Srinivasan; Singapore/SG
EE-024 Acute right lower quadrant pain in pediatric patients– A diagnostic dilemma
D. Dryga; Kyiv/UA
EE-025	Lower gastrointestinal bleeding due to NonSteroid Anti-Inflammatory Drugs (NSAIDs)-induced
colopathy
A. Pugliesi, B.M. Karim; Ludwigsburg/DE

AI, MACHINE LEARNING, RADIOMICS
EE-026	Imaging-based deep learning in liver diseases: recent
progress and future prospects
E. Yuan, Z. Ye, B. Song; Chengdu/CN
EE-027	Introduction into artificial intelligence with emphasis
on hepatic imaging
M.D. Pomohaci, M.C. Grasu, D. Popescu, I.G. Lupescu;
Bucharest/RO

POSTER PRESENTATION – EDUCATIONALHEADLINE
BILE DUCTS AND GALLBLADDER

GI TRACT – COLON

EE-028	The many faces of secondary sclerosing cholangitis– A pictorial review
M. Drucker Iarovich, K. Khalili, C. O‘Brien; Toronto, ON/CA
EE-029	An A-Z of MRCP secrets
E. Hoyles, M. Sukhanenko, B. Rea; Sheffield/UK
EE-031	Surgical lesions of biliary tract. Cholangio MRI with
hepatobiliary contrast study
I. Puig Povedano, A. Güell Barà, D. Leiva Pedraza,
J. Torras Torra, G.C. Rivera Sierra, D. Nova Vaca,
E. Alba Rey; L‘Hospitalet de Llobregat/ES
EE-032	Acute cholecystitis: diagnosis, uncommon
complications and pitfalls
P. Penalver-Calero, S. Martin-Garre, R. Mendez; Madrid/ES
EE-033	Multimodality imaging of the spectrum ofdevelopmental anomalies of liver and biliary tree
G. Reddy Poreddy1, B. Sureka2, N. Mangaraj2, P.S. Khera2,
P.K. Garg2, T. Yadav2, S. Tiwari2, R. Rajagopal2, S. Jha2,
Y. Wadhwa2, A. Agarwal2, A. Sinha2; 1Nalgonda/IN,
2
Jodhpur/IN
EE-034	It’s not all about stones – Gallbladder disorders: from
common to uncommon
D.G. Vinha, L. Maduro, A. Coutinho Santos; Lisbon/PT
EE-035	CT imaging findings of gallbladder carcinoma
C. Casanova, R. Gaio, P. Carvalho Almeida, M. Abreu,
P. Donato; Coimbra/PT
EE-036	Ultrasonographic and CT diagnosis of bilioentericfistulaA. Pavlovic, B. Miskovic, M. Dobric, A. Ristic, D. Vasin,
D. Masulovic; Belgrade/RS
EE-038	MRCP: not just for ductal stones
W. Pettit, A. Oluboyede, J. Benning, A. Tamimi; London/UK
EE-039	Cholangiocarcinoma – Spectrum of appearances
H.F. Freitas1, M. Fagulha1, J. Saraiva1, C. Bahia Soares2;
1
Portimão/PT, 2Lagos/PT

EE-042	Post imaging colorectal cancer at CT colonography
for symptomatic cases: learning from case analysis
from a high-volume centre
D. Tolan, H. Lambie, C. Roe; Leeds/UK
EE-044	Pitfalls of colorectal cancer detection in unpreparedabdominal CT scans – Lessons learnt
K. Kim, D. Kotecha, M. Amir, V. Rudralingam,
R. Magennis; Manchester/UK
EE-045	The most common bowel-wall thickening CT patterns– Clues to differential diagnosis
A. Pinto, A. Mesquita, J. Vieira, S. Dutra; Ponta Delgada/PT
EE-046	CT colonography – What a general radiologist needs
to know
J. Santos Silva, T. Oliveira, V. Mendes, H. Donato,
J. Ilharco, P. Donato; Coimbra/PT

COMPUTER TOMOGRAPHY
EE-040	Computed tomography of hypoperfusion complex
S. Lee, A. Poh; Singapore/SG
EE-041	Imaging findings of abdominopelvic andretroperitoneal fat containing lesions
D. Yang, H. Kim, S. Kim; Seoul/KR

GI TRACT – OESOPHAGUS
EE-047	Esophageal fluoroscopy: was it swallowed by modern
techniques?
I. Martinho, A.C. Vieira, A. Braga, A. Vieira; Porto/PT
EE-048	Unusual sites of oesophageal cancer recurrence andmetastasis
R. Zaher, H. Cheema, C. Grierson; Southampton/UK

GI TRACT – OTHER
EE-049	Imaging the J Pouch
T.P. Chawla, A. DeBuck, H. Macrae, R. Riddell;
Toronto, ON/CA
EE-050	Pitfalls at the ileocaecal junction: an essential review
area for the GI radiologist
M. Akobeng, V. Rudralingam, M. Amir; Manchester/UK
EE-051	Anal and perianal masses – The common, theuncommon and the rare
A. Augustine, A. Chandramohan; Vellore/IN
EE-053	The role of CT and MRI enterography in Crohn’sdisease evaluation and management
F. Ferreira, D. Carvalho, A. Madureira; Porto/PT
EE-055	Congenital diaphragmatic hernia in the paediatricpopulation
F. Coelho, J.F. Pinto, J. Amorim, M. Barros, J. Maciel,
M. França; Porto/PT

47

POSTER PRESENTATION – EDUCATIONALHEADLINE
EE-056	Phacomatoses: a pictorial review of the intraabdominal manifestations
M. Sukhanenko, E. Hoyles, B. Rea; Sheffield/UK
EE-057	Classic signs in abdominal radiology –A pictorial review
N. Seabra1, A. Manzella1, A. Alcoforado1, M. Gadelha1,
I. Cruz2, I.C. Oliveira1, J. Brito1, P. Menandro1,
M. Medeiros1; 1Recife/BR, 2São Paulo/BR
EE-058	Fat-containing lesions of the digestive tract:
imaging features
A.Y. Lecharpentier, C. Aubé; Angers/FR
EE-059	Sialography of the parotid gland
F.L. Coelho, P. Maganinho, J. Amorim, J. Maciel,
M. França; Porto/PT
EE-060	Differential diagnoses of acute appendicitis inemergency clinical practiceB. Miskovic, M. Dobric, A. Pavlovic, D. Vasin,
D. Masulovic; Belgrade/RS

EE-069	Gastrointestinal Ultrasound in Crohn‘s disease –A practical guide for beginners
J. Vuksic, D. Jovanovic; Novi Sad/RS
EE-072	Meckel‘s diverticulum and its complications –importance of the use of computed tomography
B. Maricic, D. Vasin, D. Masulovic; Belgrade/RS

GI TRACT – RECTUM

IMAGE GUIDED THERAPY

EE-062	Local recurrence of rectal cancer after surgery: therole of imaging
N. Campos, C. Terra, P. Donato, L. Curvo-Semedo;
Coimbra/PT
EE-063	Rectal adenocarcinoma after neoadjuvant therapy:
practical guide and how to avoid common mistakes
N. Horvat1, J. Miranda2, M. Fernandes1, G. Feitosa2,
G. Perdizes2, M. Queiroz2, G. Cotti2, C.F. Marques2,
C. Nahas2, S. Nahas2; 1New York, NY/US, 2São Paulo/BR
EE-064	Fooled me once: pitfalls in rectal cancer MRI post
neoadjuvant therapy
I. Kinoshita, L. Zanini, F. Velloni, R. Blasbalg,
D. Lahan-Martins; São Paulo/BR
EE-066	MR imaging of perianal fistula
A. Aguiar Ferreira, N. Campos, P. Gomes,
L. Curvo-Semedo, F. Caseiro Alves, P. Donato; Coimbra/PT

EE-075	Image guided interventions for peripancreaticcollections: A review of current best practice
E.C. Dunne, T. De Geus, F. Desmond, C. Farrelly,
L. Lawler, H. Fenlon, C. Cronin; Dublin/IE

GI TRACT – SMALL BOWEL
EE-067	Imaging spectrum of intestinal involvement in
immunocompromised state
A. Radmard1, M. Amouei1, N. Pak1, A. Davarpanah2;1
Tehran/IR, 2Atlanta, GA/US
EE-068	Small bowel thickening is not always Crohn‘sdisease. Beware of these mimickers
B. Jaber, P. Thurley, R. Singh; Derby/UK

48

GI TRACT – STOMACH
EE-073	Serosal invasion sign in gastric and colon cancer:
a radiologic-pathologic correlation
A. Djuric-Stefanovic, J. Kovac, L. Lazic, M. Mitrovic,
A. Jankovic, D. Saponjski; Belgrade/RS
EE-074	Imaging of bariatric surgery: normal anatomy
and postoperative complications
M. Urizar Gorosarri1, E. Alcalde1, V. Barcena1, R. Fornell1,
A. Ibañez1, M. Isusi1, G. Lecumberri1, A. Quilez1,
D. Pereira2; 1Bilbao/ES, 2Madrid/ES

LIVER – DIFFUSE LIVER DISEASE
EE-076	Liver manifestation of storage and overload
disorders: an imaging guide
G. Porrello, M. Antonucci, R. Cannella, G. Brancatelli;
Palermo/IT
EE-077	Hepatic fat fraction – Pitfall to avoid
F. Weng1, N. Adams1, E. Resnick2; 1Portland, ME/US,
2
Falmouth, ME/US
EE-078	Liver iron quantification, MRI imaging techniques
C. Finan1, M. O’brien2, A. Abdellaoui2, B. Fox2; 1Ivybridge/UK,
2
Plymouth/UK
EE-079	Diffuse and focal fatty liver disease (FLD), imaging
techniques and pitfalls
C. Finan1, M. O’brien2, A. Abdellaoui2, B. Fox2; 1Ivybridge/UK,
2
Plymouth/UK

POSTER PRESENTATION – EDUCATIONALHEADLINE
LIVER – FOCAL LIVER LESIONS
EE-080	Hepatocellular carcinoma – A single name fordiverse types
S.K. Venkatesh1, S.M. Thompson1, J. Wang2,
M.S. Torbenson1; 1Rochester, MN/US, 2Guangzhou/CN
EE-081	Ensuring your LI-RADS reporting is in MiNT
condition: a mnemonic for the often overlooked LIRADS decision tree
D. Kennedy, M. Shiehmorteza, S. Eberhardt, M. Terrazas,
N. Keshav; Albuquerque, NM/US
EE-082	Cirrhotic nodules – The spectrum from regeneration
to malignization
A.Q. Fonseca, A.L. Proença, N. Gião; Lisbon/PT
EE-083	Fat-containing liver lesions: what all abdominal
radiologists should know
E. Reizine, S. Mulé, L. Baranes, B. Zegai, D. Marjan,
G. Amaddeo, A. Luciani; Créteil/FR
EE-084	Liver abscess: pictorial review of typical and atypicalpresentations
E. Awiti, E. Reizine, M. Blain, S. Mulé, F. Pigneur,
H. Kobeiter, A. Luciani; Créteil/FR
EE-085	Cystic hepatic lesions: a review of imaging features
B. Giesteira, J. Sousa, P. Maganinho, J. Amorim,
E. Melo Abreu, M. França; Porto/PT
EE-086	Subcentimeter size hypervascular nodules in an
at-risk liver – Etiopathogenesis, factors impacting
diagnosis, and an algorithmic approach to theirdiagnosis and management using Lirads
D. Lokhandwala1, D. Mehta1, S. Siddiqui1, S. Sabnis1,
S. Nellore2, S. Jalkote1, K. Ganesan1; 1Mumbai/IN,
2
Navi Mumbai/IN
EE-087	Hepatic sclerosed haemangioma
G. Culleton, S. Dunnion, A. Nixon, P. Blair, A. Wray,
J. Lyske; Belfast/UK
EE-088	Contrast-enhanced ultrasound (CEUS): basic
principles and assessment of focal liver lesions
R.G. Santos, C. Casanova, P. Almeida, P. Donato;
Coimbra/PT
EE-090	Intrahepatic and perihilar cholangiocarcinomas:
current concepts and imaging findings with radiopathologic correlation
C. Senra, F. Marques dos Santos, C. Mota, A. Almeida;
Vila Nova de Gaia/PT
EE-091	Pyogenic liver abscesses – spectrum of imaging
findings
C. Mota, I. Matos, C. Senra, F. Antunes, F. Marques dos
Santos, A. Almeida; Vila Nova de Gaia/PT

EE-092	Fat containing liver lesions – Aiding the diagnosis
J. Sardinha1, B. Gaspar1, G. Saldanha1, J. Palas2, J.
Pereira1; 1Almada/PT, 2Setúbal/PT
EE-093	MRI evaluation of multifocal liver lesions – An
illustrated review
A. Mesquita1, D. Carvalho2, A.L. Pinto1, J. Vieira1, M. Clara
Sousa1, R. Cruz1; 1Ponta Delgada/PT, 2Porto/PT

LIVER – OTHER
EE-094	Liver ligaments: what we must know
T. Marques, E. Pacheco, D. Tiferes, U. Torres,
G. D‘Ippolito; São Paulo/BR
EE-095	Hepatic sinusoidal dilatation – The role of theradiologist in the diagnosis
V. Pires, S. Basso, L. Curvo-Semedo, F. Caseiro Alves,
P. Donato; Coimbra/PT
EE-098	Budd Chiari syndrome: a case review of thediagnostic and interventional radiological findings
C. Keshvala, R. Singh, B. Jaber, P. Thurley, A. Lawson;
Derby/UK
EE-099	Hepatic capsular retraction: not everything ismalignant
B. Gaspar, F. Sardinha, G. Saldanha, J. Pereira,
A. Gonçalves; Almada/PT
EE-100	Non cirrhotic portal hypertension revisited: role ofradiologists in its diagnosis
B. Sureka, Y. Wadhwa, D. Singh, T. Yadav; Jodhpur/IN
EE-101	Liver MRI optimisation of protocol and contrast
C. Finan1, M. O’brien2, A. Abdellaoui2, B. Fox2; 1Ivybridge/UK,
2
Plymouth/UK

LIVER – TRANSPLANTATION
EE-102	Biliary complications of liver transplantation inpediatric patients: an overview of percutaneoustranshepatic cholangiography findings
L. Dulcetta1, P. Marra1, F. Carbone1, B. Di Fazio1, R.
Muglia1, P.A. Bonaffini1, S. Sironi2; 1Bergamo/IT, 2Milan/IT

MAGNETIC RESONANCE
EE-103	MR imaging of non-gynecologic pelvic lesions
K. Kim, Seoul/KR

49

POSTER PRESENTATION – EDUCATIONALMISCELLANEOUS
EE-105	Classifying splenic lesions: an ongoing imaging
conundrum
J.Y. Patel, T. Mistry; London/UK
EE-106	“To be or not to be:” mimics of abdominal malignancy
J.Y. Patel, C. Horst, A. Elowaidy; London/UK
EE-107	Oral contrast agents: complications and adverse
reactions
I. Gigantelli1, G. Tessarin2, E. Tramarin2, F. Morra2,
A. Schillaci2, S. Cattarin2, I. Mercante2, F. Greco1,
G. Piccoli1, E. Quaia2; 1Conegliano/IT, 2Padua/IT
EE-108	Imaging patterns of abdominal gasI
L. Sá Marques, C. Terra, D. Andrade, L. Curvo-Semedo;
Coimbra/PT
EE-109	Contrast media in gastrointestinal imaging – What
we know, do not know, and should know
B. Sureka, P. Khera, P. Garg, T. Yadav, S. Tiwari; Jodhpur/IN
EE-111	Retroperitoneal hibernoma
G. Culleton1, S. Dunnion1, A. Nixon1, P. Blair1, A. Wray1,
S. Shukla1, F. McCloskey2, J. Lyske1; 1Belfast/UK,
2
Holywood/UK
EE-112	Castleman’s disease: demystifying a rare entity
T. Skok, N. Boc, V. Jugovec; Ljubljana/SI
EE-113	Don‘t forget about abdomen radiographs just yet:clues from calcium
D. DiSantis, J. Cernigliaro; Jacksonville, FL/US
EE-114	Multiparametric renal MRI
C. Finan1, M. O’brien2, A. Abdellaoui2, B. Fox2; 1Ivybridge/UK,
2
Plymouth/UK

ONCOLOGY
EE-116	Revisiting response assessment of colorectal liver
metastases: lessons learned and opportunities for
improvement
L.P. Marcal, S. Yedururi, E. Loyer; Houston, TX/US
EE-117	An uncommon location of a “common” condition:
abdominal manifestations of malignant peritoneal
mesothelioma
G. Porrello, R. Cannella, M. Antonucci, G. Brancatelli;
Palermo/IT
EE-118	Assessing therapeutic response after loco-regional
hepatocellular carcinoma treatment
N. Campos, L. Curvo-Semedo, F. Caseiro Alves,
P. Donato; Coimbra/PT

50

EE-119	A practical guide for imaging evaluation of liver
ablation: pearls, pitfalls and emerging techniques
L. Kafaei, L. Pendower, E. Johnston, N. Khan, J. Mccall,
N. Fotiadis, A. Riddell, D.-M. Koh, J. Shur; London/UK
EE-120	Lymphoma of the gastro-intestinal tract: CT and MRI
radiological features
A. Calabrese, A. Longhi, L. Busato, F. Maccioni; Rome/IT
EE-121	Extra-gastrointestinal stromal tumors
P. Sousa, A. C. Ferreira; Loures/PT
EE-122	Missed CT lesions of abdominal oncologic patients:case series
K. Sim, B. Park, D. Sung, M. Kim, N. Han, Y. Han; Seoul/KR
EE-124	Abdominopelvic manifestations of extranodal
lymphoma: a pictorial review
L. Maduro1, M. Rosa2; 1Carnaxide/PT, 2Lisbon/PT
EE-125	Abdominal multiorgan involvement of plasmacytoma– A case series review
C. Mendonça, A.R. Azeiteiro, M. Leite, J. Leitão; Lisbon/PT

PANCREAS BENIGN LESIONS
EE-126	Paraduodenal pancreatitis, an overlooked cause ofgastrointestinal obstruction
M.V. Dias, S. Teixeira, H. Gomes, J. Monteiro, D. Cardoso,
D. Silva; Viseu/PT
EE-127	An abbreviated MRI protocol for follow-up cystic
pancreatic lesions
A. Morcillo Cabrera; Las Palmas de Gran Canaria/ES

PANCREAS DIFFUSE DISEASE
EE-130	Acute pancreatitis: spectrum of imaging findings
based on the revised Atlanta classification
T. Santos Oliveira, V. Mendes, J. Santos Silva,
C.M. Oliveira, L. Curvo-Semedo, P. Donato; Coimbra/PT
EE-131	Role of percutaneous catheter drainage in the „Stepup“ approach in the management of severe acutepancreatitis
M. Kang, P.S. Chowhan, S.S. Rana, R. Gupta, U. Gorsi,
M. Sandhu; Chandigarh/IN

POSTER PRESENTATION – EDUCATIONALPANCREAS MALIGNANT LESIONSULTRASOUND

EE-132	The variety of pancreatic IPMN complications
C. Triantopoulou, A. Doukopoulou, I. Christofilis,
L. Adamopoulou, K. Vitzileos, A. Karouta,
G. Anastopoulos; Athens/GR
EE-133	Ignore the isolated pancreatic duct at your peril!
H. Perry, S. Senthil, A. Razack; Hull/UK
EE-134	Solid pancreatic focal lesions: diagnosis andmanagement
A. Veron Sanchez, M. Pezzullo, M. Zaiter, P. Demetter,
M. Van Wettere, M.A. Bali; Brussels/BE
EE-135	Reporting pancreatic malignancies: what thesurgeons want to know
H. Perry, S. Senthil, A. Razack; Hull/UK
EE-136	Imaging review of metastatic disease to thepancreatic gland
G. Maskell1, C. Greer1, C. Bullock2, M. Strugnell1,
H. Barton3, D. Shetty1; 1Truro/UK, 2Exeter/UK, 3Bristol/UK
EE-137	Cavitating pulmonary metastases as presentation ofa mucinous cystadenocarcinoma of the pancreas
D. Bhatt, R. Sinha; Warwick/UK

EE-143	Contrast-enhanced ultrasound in Crohn‘s disease:technique, image interpretation and clinicalapplications
T. Fragkouli, S. Athanasiou, D. Cokkinos, C. Sierrou,
I. Melissovas, R. Tzouvaras, P. Lerios, S. Tsolaki,
D. Exarhos, I. Kalogeropoulos; Athens/GR
EE-144	Advanced sonographic perfusion imaging techniquesin bowel pathology
K. Biernacka-Racicot, D. Baranska, P. Grzelak; Lodz/PL
EE-146	Role of superb microvascular imaging: the end of“The Hypoechoic Nodule Dilemma”?
S. Martin-Garre, S. Gill, J. Barrera Ortega; Madrid/ES
EE-147	Determining measurement sites to assess theinter-recti distance with ultrasound imaging forphysiotherapy purposes
A. Opala-Berdzik, M. Rudek-Zeprzałka, J. Niesporek,
M. Cebula, J. Baron, K. Gruszczyńska, D. Chmielewska;
Katowice/PL

PELVIC FLOOR

EE-148	Imaging atlas of peritoneal anatomy
A. Bhagwanani, R. Zaher, J. El-Sheikha, D. Patel,
O. Duxbury, N. Shah, A. Thrower; Basingstoke/UK
EE-149	Meet the mesentery – So long forgotten,
so much to tell
A. Borges, C. Antunes, L. Curvo-Semedo, P. Donato;
Coimbra/PT
EE-150	A great mimicker: the many faces of peritoneal
mesothelioma
N. Campos, C. Terra, P. Donato, L. Curvo-Semedo;
Coimbra/PT
EE-151	The peritoneum: an anatomical structure of theabdomen radiologists should know about
R. Borrero León, P.A. Forero, D.F. Torres, D.A. Aguirre,
N. Bedoya; Bogotá/COEE-138	Role of anoperineal MRI in the management ofanoperineal lesions in Crohn‘s disease
M. Haouari, I. Boulay Coletta, M. Zins; Paris/FR
EE-139	Sacropexy complications: imaging findings
M. Haouari, T. Caroline, I. Boulay Coletta, M. Zins; Paris/FR
EE-140	Retro-rectal tailgut duplication cysts: spotting raremalignant transformation
T. Glover, L. Gould, P. Tozer, E. Burns, I. Jenkins,
D. Burling, A. Corr; London/UK
EE-141	Trouble brewing below: imaging infection of theurogenital and anal triangle
Z. Bhebhe, J. Straiton; Douglas/IM

WALL, PERITONEUM, MESENTERYTECHNICAL ADVANCES
EE-142	Diffusion weighted imaging in the abdomen andpelvis: recent technical advances and future
perspectives
T. Yang, Z. Ye, S. Yao, B. Song; Chengdu/CN

51

POSTER PRESENTATION – SCIENTIFICABDOMINAL VASCULAR IMAGING

AI, MACHINE LEARNING, RADIOMICS

SE-001	Portal blood flow in the remnant portal branches isincreased after percutaneous transhepatic portal
vein embolization (PTPVE) for biliary tract cancer: ananalysis with 4D flow MRI
R. Hyodo, Y. Takehara, T. Mizuno, K. Ichikawa,
M. Sugiyama, T. Ebata, S. Naganawa; Nagoya/JP
SE-002	A flowmetry study of superior mesenteric arteryusing 4D-Flow MRI – Efficient blood delivery to thesuperior mesenteric artery might be reduced in
abdominal aortic aneurysm patients compared to thecontrols with non-dilated abdominal aorta
M. Sugiyama1, Y. Takehara1, T. Ushio2, T. Wakayama3,
A. Nozaki3, S. Goshima2, S. Naganawa1; 1Nagoya/JP,
2
Hamamatsu/JP, 3Hino/JP
SE-004	Transcatheter embolization control of the upper
abdominal bleeding
Y.-M. Ku, Y. Won; Uijeongbu/KR
SE-005	Computerised tomography, an alternative diagnostic
tool for surveillance oesophageal varices
D. Jothimani, S. Joshua Muthuchand, B. Nallathambi,
B. Pandurangan, S. Kalyanasundaram, K. Subbiah,
H. Ramachandran, R. Venugopal, D. Dhas, M. Rela;
Chennai/IN

SE-014	Prediction of post-hepatectomy liver failure inpatients with hepatocellular carcinoma: developmentof a radiomics model
Q. Wang1, C. Li2, M. Kuansheng2, T. Brismar1;
1
Stockholm/SE, 2Chongqing/CN
SE-015	Artificial Intelligence based image quality
enhancement in liver MRI: a quantitative andqualitative evaluation
B. Masci, M. Zerunian, F. Pucciarelli, D. Caruso, M. Polici,
G. Guido, D. De Santis, E. Iannicelli, A. Laghi; Rome/IT
SE-016	Effectiveness of a state-of-the-art neural network
for liver parenchyma, portal and hepatic veinsegmentation based on a standard non-contrast T1vibe Dixon sequence
L. Zbinden1, D. Catucci2, Y. Suter1, A. Berzigotti1, L. Ebner1,
A. Christe1, V. Obmann1, R. Sznitman1, A. Huber1; 1Bern/CH,
2
Herrenschwanden/CH
SE-017	A preliminary research on the CT-based texture
analysis working as a predictive method forstratifying clinically significant portal hypertension
S. Wan, Y. Wei, X. Zhang, B. Song; Chengdu/CN
SE-018	Feasibility and performance of Artificial Intelligence(AI) for pancreatic segmentation and volume
measurement using magnetic resonance imaging(MRI) – Results from a multi-institutional study(minimap)
J. Ha1, X. Zhang1, E. Fogel2, P. Territo2, S. Persohn2,
T. Tirkes2; 1Bloomington, IN/US, 2Indianapolis, IN/US
SE-019	Portal hypertension: CT texture signature based onmachine learning method as a predictive index ofpatients‘ survival
S. Wan, Y. Wei, X. Zhang, B. Song; Chengdu/CN
SE-020	Deep learning image reconstruction vs. adaptive
statistical iterative reconstruction in virtualmonoenergetic dual-energy CT
J.J. Xu; Copenhagen/DK
SE-021	Prognostic value of radiomic analysis of contrastenhanced CT in hepatocellular carcinoma:
preliminary results
S. Viganò1, P.A. Bonaffini2, A. Corsi3, E. De Bernardi1,
C. Bandini1, E. Piccin1, C. Valle4, P. Marra1, S. Sironi1;
1
Milan/IT, 2Bergamo/IT, 3Viareggio/IT, 4Monza/IT

ACUTE ABDOMEN
SE-007	Impact of MDCT imaging on predicting the surgicalmanagement in acute diverticulitis
S. Merola; Narbonne/FR
SE-008	The stranded stone: relationship between acuteappendicitis
S. Merola; Narbonne/FR
SE-009	Role of MDCT in the management of intestinal
obstruction
S. Merola; Narbonne/FR
SE-010	Small bowel perforation
A. Gyliene, V. Straksyte, I. Idzelyte, A. Basevicius;
Kaunas/LT
SE-011	The potential of MDCT in diagnosis of atypical acuteappendicitis
S. Merola; Narbonne/FR
SE-012	Diffusion-weighted imaging for acute appendicitis inpregnancy – An underutilised sequence?
B.W. Buckley, F. Delaney, I. Welaratne, C. Cronin; Dublin/IE

52

POSTER PRESENTATION – SCIENTIFIC
SE-022	CT-based radiomics for prediction of therapeutic
response to Everolimus in metastatic neuroendocrine
tumorsM. Polici, M. Zerunian, I. Nacci, G. Guido, E. Iannicelli,
D. Caruso, A. Laghi; Rome/IT
SE-024	Preoperative prediction for the pathological gradeof hepatocellular carcinoma via contrast-enhanced
computed tomography-based radiomics model
M. Shantarevich, E. Kondratyev, G. Karmazanovsky;
Moscow/RU
SE-025	Deep learning HASTE sequence for liver MRI at
3 Tesla: qualitative and quantitative prospective
comparative study
P. Wary1, G. Hossu2, K. Ambarki3, M. Dominik4,
S. Arberet5, J. Oster2, X. Orry2, V. Laurent2; 1Nancy/FR,
2
Vandoeuvre-lès-Nancy/FR, 3Saint Denis/FR, 4Erlangen/DE,
5
Princeton, NJ/US

BILE DUCTS AND GALLBLADDER
SE-026	Primary sclerosing cholangitis: qualitative andquantitative evaluation at 3T MRI
P. Boraschi, V. Mazzantini, F. Donati, M. Tarasenko,
B. Coco, B. Vianello, M. Brunetto, E. Neri; Pisa/IT
SE-027	A retrospective evaluation of gallbladder cancer
diagnosis in our institution
E. Hoyles, B. Rea, K. Hoyles, P. Kitsanta; Sheffield/UK
SE-028	Relating LFTs to choledocholithiasis at MRCP
S. Bready, S. Ballantyne; Glasgow/UK
SE-029	Feasibility study to assess the potential clinical utility
and value of MRCP+ in the diagnostic, monitoringand management of patients with primary sclerosing
cholangitis
P.J. Trivedi1, M. Moawad2, M. Pansini2, J. Hart2, M. Bajre2;
1
Birmingham/UK, 2Oxford/UK

COMPUTER TOMOGRAPHY
SE-030	Myosteatosis is a key pathological trait inasymptomatic adults
M. Nachit1, Y. Horsmans1, R. Summers2, I. Leclercq1,
P.J. Pickhardt3; 1Brussels/BE, 2Bethesda, MD/US,
3
Madison, WI/US
SE-031	Are pre-operative CT variables associated with thesuccess or failure of subsequent ventral hernia
repair: nested case-control study
S. Kumar1, N. Rao2, S. Parker1, A. Plumb1, A. Windsor1,
S. Mallett1, S. Halligan1; 1London/UK, 2Coventry/UK

SE-033	Comparison of peer teaching versus radiology
resident teaching in radioanatomy education
S. Jacquemin, A. Maazouzi, C. Aubé, A. Paisant;Angers/FR

GI TRACT – COLON
SE-034	The impact of fit triage on a large CT colonoscopy
service
S. Srinivas, R. Balasubramaniam; Stoke on Trent/UK
SE-035	Preoperative computed tomography assessmentof circumferential resection margin in
retroperitonealized colon cancer predicts diseasefree survival
N. Seo, J. Lim; Seoul/KR
SE-036	Comparison of two different bowel preparation
regimes for CT colonography
S. Stinchcombe, E. Sobiesinski; Sutton-in-Ashfield/UK
SE-037	CTC findings in population-based screening forcolorectal cancer in the Netherlands
R. Schreurs; Venlo/NL

GI TRACT – RECTUM
SE-038	Prediction of overall survival in rectal cancer
patients by combined tumor-mesorectum radiomics
characterization
A.M. Marhuenda Fluixá1, E. Remacha1, I. Machado1,
R. Garcia-Figueiras2, L. Oleaga3, J. Cervera Deval1,
L. Martí-Bonmatí1, A. Alberich Bayarri1; 1Valencia/ES,
2
Santiago de Compostela/ES, 3Barcelona/ES
SE-039	Mucinous degeneration on rectal MRI after
neoadjuvant therapy followed by total mesorectal
excision and its clinical impact
N. Horvat1, J. Miranda2, F. Kinoshita2, P. Pinto2,
R. Pandini2, C. Nahas2, S. Nahas2; 1New York, NY/US,2
São Paulo/BR
SE-040	T staging of anal cancer
A.W. Fries, B.M. Havelund, S.R. Rafaelsen; Vejle/DK
SE-041	Pathological response assessment after neoadjuvant
treatment in rectal cancer using MRI-based radiomic
model
J. Miranda1, N. Horvat2, A. Assuncao-Jr1, F. Machado1,
C. Nahas1, S. Nahas1, C.H. Nomura1; 1São Paulo/BR,
2
New York, NY/US

53

POSTER PRESENTATION – SCIENTIFIC
SE-042	Retrospective analysis of the adherence to the rectal
cancer deferral of surgery protocol
S. McFaul1, T. Coyle2, S. Evans2; 1Glasgow/UK, 2Paisley/UK
SE-044	Do 3D MRI sequences are more informative thanconventional 2D MRI sequences in presurgicalassessment of perianal fistula? A prospective study
V. Kasi Arunachalam, A. K V; Coimbatore/IN
SE-045	MRI evaluation of the response of rectal cancer
therapy: qualitative and quantitative assessment
M. Radzina, M. Ratniece, K. Julija, M. Liepa,
M. Mikelsone; Riga/LV
SE-046	Observer variability in magnetic resonance imaging
measurements in rectal cancer
P. Grimm, M.K. Loft, C. Dam, M.R. Pedersen, S. Timm,
S.R. Rafaelsen; Vejle/DK

IMAGE GUIDED THERAPY
SE-048	Biodegradable biliary stents in biliary strictures after
liver transplantation: experience of our center
C. Terra, D. Diogo, E. Furtado, A. Gil Agostinho,
M. Portilha, P. Donato; Coimbra/PT
SE-049	Therapeutic CT-guided drainage of hepatic
abscesses – Our experience
V. Valek, T. Rohan, T. Andrasina; Brno/CZ

LIVER – DIFFUSE LIVER DISEASE
SE-051	Gaucher disease: assessment by multiparametric
MRI and MR elastography of the liver and spleen
D. Parente, F. Chagas Malta, R. Cravo, R. Rodrigues,
R. Perez; Rio de Janeiro/BR
SE-052	MRI findings of hepatic iron overload, steatosis, andtheir overlapping: what do they mean? Correlation
between MRI findings, biochemical markers and HFEgenetic testing – A study of 2,630 cases
D. Tiferes, P. Oliveira, M. Cavichio, S. Tahan, U. Torres,
G. D‘Ippolito, A. Caiado; São Paulo/BR
SE-053	Chemotherapy-associated liver injury (CALI) in
patients with colorectal liver metastases: evaluation
with 3T MR imaging
F. Donati, M. Tarasenko, P. Boraschi, V. Mazzantini,
B. Borelli, R. Moretto, P. Colombatto, L. Urbani, E. Neri;Pisa/IT
SE-055	MRI techniques for the evaluation on liver fat
content: comparison between different techniques
F. Pucciarelli, M. Zerunian, M. Polici, B. Masci, B. Bracci,
A. Del Gaudio, E. Iannicelli, D. Caruso, A. Laghi; Rome/IT

54

SE-056	The usefulness of MRI assessment of ectopic fat
accumulation in pancreas, liver and skeletal muscle
in correlation with the presence of central obesity
and metabolic syndrome
J. Pienkowska, B. Brzeska, O. Kozak, E. Szurowska;
Gdansk/PL

LIVER – FOCAL LIVER LESIONS
SE-058	MRI features associated with HCC histologic
subtypes and combined HCC-cholangiocarcinoma:a Western American and European bicenter study
S. Mulé1, A. Serhal2, A. Galletto Pregliasco1, J. Nguyen2,
G. Amaddeo1, C. Vendrami2, J. Calderaro1, G.-Y. Yang2,
A. Luciani1, F. Miller2; 1Créteil/FR, 2Chicago, IL/US
SE-059	Lirads V2018: a pictorial update
H. Dillon; Dublin/IE
SE-060	Gadoxetic acid-enhanced MRI for prediction of
microvascular invasion in solitary hepatocellular
carcinoma: A preliminary study with stratification bytumor size
H. Wei, B. Song; Chengdu/CN
SE-062	Noninvasive identifying of Sox9-positive
hepatocellular carcinoma using radiomics
signatures: a retrospective and observational study
F. Che, Y. Wei, B. Song; Chengdu/CN
SE-063	Diagnostic performance of MRI and CEUS in
differentiating intrahepatic cholangiocarcinoma fromhepatocellular carcinoma: a meta-analysis
Y.Y. Wu, Z. Ye, J. Chen, Q. Qin, B. Song; Chengdu/CN
SE-064	Diagnostic performance of two kinds of abbreviatedGadoxetic acid-enhanced MR protocols with orwithout contrast-enhanced CT for the detection ofcolorectal liver metastases
K. Ozaki1, S. Higuchi1, H. Kimura1, T. Gabata2; 1Eiheiji/JP,
2
Kanazawa/JP
SE-065	The value of quantitative diffusion-weighted
imaging in characterization of hypovascular liverlesions: a comparison between intravoxel incoherent
motion derived parameters and apparent diffusion
coefficient
J.D. Kovac, A. Jankovic, M. Dakovic, A. Djuric-Stefanovic;
Belgrade/RS
SE-066	Compression MR elastography to assess
microvascular invasion in patients with
hepatocellular carcinoma
G. Pagé1, P. Garteiser1, V. Paradis1, R. Sinkus1, V. Vilgrain1,
B. Van Beers2; 1Paris/FR, 2Clichy/FRPOSTER PRESENTATION – SCIENTIFIC
SE-067	The role of magnetic resonance imaging in predicting
hepatocellular carcinoma with progenitor phenotype:a meta-analysis
Q. Qin, B. Song, J. Chen, Z. Ye, Y.Y. Wu; Chengdu/CN
SE-068	Perfusion CT of HCC: correlation to LIRADS V2018
major features
G. Kalarakis1, T. Brismar1, A. Svensson1, M. Fischer2;
1
Stockholm/SE, 2Zurich/CH

LIVER – OTHER
SE-071	Estimation of liver fibrosis by MRI-elastography
in the patient with chronic liver disease
F. Ascari1, P. Torricelli1, G. Ligabue1, A. Pecchi2;
1
Modena/IT, 2Carpi/IT
SE-072	Selective internal radiation therapy for hepatocellular
carcinoma in Angers, a retrospective cohort study
2012-2020
I. Oreistein, C. Aubé, A. Bouvier, A. Paisant; Angers/FR

LIVER – TRANSPLANTATION
SE-074	Impact of preoperative skeletal muscle index on
remnant liver regeneration in living donors after livertransplantation
S. Lee, K. Kim; Seoul/KR
SE-075	Role of pre-operative imaging in living liver donortransplantation
I. Garuti1, F. Lorenzetti1, B. Catellani1, F. Di Benedetto1,
S. Di Sandro1, G. Ligabue1, P. Torricelli1, A. Pecchi2;
1
Modena/IT, 2Carpi/IT
SE-076	Color-Doppler US in the diagnosis and interventional
radiological management of portal anastomotic
obstruction during the follow up of pediatric livertransplantation
F. Carbone1, P. Marra1, L. Dulcetta1, B. Di Fazio1,
R. Muglia1, P.A. Bonaffini1, S. Sironi2; 1Bergamo/IT,
2
Milan/IT

SE-078	Simultaneous multislice diffusion-weighted
imaging in patients with hepatocellular carcinoma:
respiratory-triggered versus breath-holding
S. Yao, Z. Ye, T. Yang, B. Song; Chengdu/CN

MISCELLANEOUS
SE-079	Evaluate the correct management of the oncologicalpatient in a multidisciplinary perspective, with reevaluation and characterization of the disease at
the meetings of the multidisciplinary team (MTM)
and therefore demonstrate the superiority of an
integrated MTM approach compared to the limited
and non-specific mono-specialistic evaluation andallow the best therapeutic treatment available thanks
to the exchange of multidisciplinary knowledge andexperience
L. Tomaiuolo, A. Olivieri, L. Geraci, D. Autelitano,
M. Todesco, C. Longo, F. Cicalo‘, F. Verrengia, F. Moro,
A. Carli, F. Spoto, V. Rossi, C. Cacciatore, F. Segato,
V. Bissoli, R. De Robertis, M. D‘Onofrio; Verona/IT
SE-081	Integration of abdominal imaging into a grossanatomy Medical School Curriculum
E.J. Torralba1, J. Kunzelman2, A.M. Silva1, D.X. Parmelee1,
A.C. Silva2; 1Dayton, OH/US, 2Scottsdale/Phoenix, AZ/US
SE-082	Imaging side effects and complications ofantineoplastic therapy in gastrointestinal tract –A pictorial review
G. Al-farra; Herlev/DK

ONCOLOGY
SE-083	Associations between contrast-enhanced CT images
and Kit Exon 11 gene mutation in gastrointestinal
stromal tumors
C. Yang; Chengdu/CN

MAGNETIC RESONANCE
SE-077	Comparison of a commercial 3D-Dixon sequence anda standardized ME-GRE-R2* relaxometry method inquantifying splenic and pancreatic iron
M. Plaikner, L. Lanser, C. Kremser, G. Weiss,
B. Henninger; Innsbruck/AT

55

POSTER PRESENTATION – SCIENTIFICPANCREAS DIFFUSE DISEASE
SE-085	Accuracy of a CT density threshold enhancement
in distinguishing pancreas parenchymal necrosis incases of acute pancreatitis in the first week
R. le Guen, I. Ben Rhouma, G. Herpe, A. Guerrab,
P. Ingrand, J.-P. Tasu; Poitiers/FR
SE-086	Evaluation of visceral adiposity and its role inpredicting severity in acute pancreatitis: correlation
with CT severity index and clinical outcome
M. Kang, V. Dev A, U. Gorsi, S. S. Rana, R. Gupta,
M. Sandhu; Chandigarh/IN
SE-088	Place of imaging in acute and chronic pancreatitis
A. Meunier; Angers/FR

SE-094	Impact of bowel-preparation methods on pancreatic
magnetic resonance elastography
A.-S. van Schelt1, N.P. Wassenaar1, E.M. Schrauben1,
J.L. Nelissen1, J. Guo2, I. Sack2, J. Stoker1,
A.J. Nederveen1, J. Runge1; 1Amsterdam/NL, 2Berlin/DE

TECHNICAL ADVANCES
SE-097	Radiofrequency ablation in pancreatic
adenocarcinoma: CT study of thermo-lesion andmarginal area with texture analysis
M. Todesco, L. Geraci, L. Tomaiuolo, D. Autelitano,
A. Carli, A. Olivieri, F. Verrengia, R. De Robertis,
M. D‘Onofrio; Verona/IT

PANCREAS MALIGNANT LESIONSULTRASOUND

SE-089	Analysis of CT findings in patients with different
serum pancreatic amylase trends after majorpancreatic resections
M. Bariani, F. Mambrin, G.A. Zamboni, M. Ambrosetti,
E. Bannone, G. Marchegiani, R. Salvia, G. Mansueto;
Verona/IT
SE-090	Quantitative edge analysis of pancreatic margins
in patients with head pancreatic adenocarcinoma:correlations between pancreatic margins and onsetof postoperative pancreatic fistula
C. Gasparini1, M. Ambrosetti1, G.A. Zamboni1,
A. Ambrosetti2, G. Mansueto1, G. Marchegiani1, G. Perri1,
R. Salvia1, S. Montemezzi1; 1Verona/IT, 2Padua/IT
SE-091	Understanding the ablation zone – Irreversible
electroporation of pancreatic cancer
O.W. Kozak, H. Stanislaw, J. Pienkowska, K. Skrobisz,
M. Szymanski, M. Studniarek; Gdansk/PL
SE-092	Utility of PET-CT in management of pancreaticmalignancies
M. Khalid, H. Perry, N. Ahmed, A. Razack; Hull/UK

SE-098	Contrast-enhanced ultrasound (CEUS) is excellent
for follow-up of abdominal trauma patients initially
examined with CECT. Radiologists in training can doit and patients prefer it to CECT
D. Cokkinos, C. Sierrou, S. Tsolaki, T. Fragkouli, V. Panou,
M. Papadopoulou, K. Papachristos, G. Skoufogiannis,
A. Boultadaki, I. Kalogeropoulos; Athens/GR
SE-099	Assessment of pancreas tissue stiffness among
healthy subjects
B. Almutairi, G.A. Alghamdi, R.W. Edrees, A.A. Althubaity,
R. Abdeen, F.F. Almutairi; Jeddah/SA
SE-100	A single-center, retrospective study comparing
the number of non-diagnostic measurements of
the PSWE and SSI liver ultrasound elastography
examinations
M. Cebula, A. Biernacka, K. Gruszczynska; Katowice/PL

QUANTITATIVE IMAGING
SE-093	Distinct phenotypes of multi-organ abnormalities
in long COVID and type 2 diabetes identified bymultiparametric MRI
N. Eichert1, A. Telford1, A. Roca-Fernandez1, A. Hamid1,
M. Pansini1, H. Thomaides-Brears1, A. Dennis1,
R. Banerjee1, S. Alu1, G. Thanabalasingham1, G.J. Kemp2,
D.J. Cuthbertson2, A. Banerjee3; 1Oxford/UK,
2
Liverpool/UK, 3London/UK

56

WALL, PERITONEUM, MESENTERY
SE-102	What is the optimum protocol for post treatment
surveillance imaging of mucinous appendiceal
neoplasms?
P.J. Dempsey, J.W. Power, A. Yates, L. Martin-Roman,
J.J. Aird, J. Mulsow, H. Fenlon, C. Cronin; Dublin/IE

CORPORATE MEMBERS,
INDUSTRY & SPONSORS

57

ULTRASOUND VILLAGE
Scientific Coordinators:
J.B.C.M. Puylaert, The Hague/NL; M. Ramalho, Almada/PT
At ESGAR 2022, the modality of ultrasound will be one of the highlighted topics.
Throughout the meeting, sessions, tutorials and keynote lectures will encompass basic
technical aspects as well as innovations in abdominal ultrasound, as contrast-enhanced
ultrasound and new techniques such as elastography, fusion imaging and 3D. However,there will also be ample attention for the clinical triage-function of ultrasound as a primarytool, workhorse and starting point in any abdominal problem.

WEDNESDAY, JUNE 1, 2022

THURSDAY, JUNE 2, 2022

FRIDAY, JUNE 3, 2022

08:00 – 08:45 USV 1 Keynote Lecture

08:00 – 08:45 USV 7 Keynote Lecture

09:25 – 10:15 USV 13 Keynote Lecture

08:50 – 09:30 USV 2 Keynote Lecture

08:50 – 10:20 USV 8 Keynote Lectures

11:00 – 11:45

09:40 – 10:30 USV 3 Keynote Lecture

11:00 – 11:30 USV 9 US Live Demo

11:45 – 12:45 USV 15 Hands-on Training

11:00 – 12:00 USV 4 Hands-on Training

11:30 – 12:30 USV 10 Hands-on Training

14:00 – 15:30 USV 5 Keynote Lectures

14:00 – 15:30 USV 11 Keynote Lectures

15:30 – 16:30 USV 6 Hands-on Training

15:30 – 16:30 USV 12 Hands-on Training

USV 14 Keynote Lecture

THE ULTRASOUND VILLAGE IS KINDLY SUPPORTED BY:

58

ESGAR WISHES TO GRATEFULLY ACKNOWLEDGE THE SUPPORTOF ITS CORPORATE MEMBERS

INDUSTRY SPONSORED PROGRAMME – OVERVIEWTUESDAY, MAY 31, 2022

THURSDAY, JUNE 2, 2022

12:15 – 13:15

12:45 – 13:45

SY 1

BAYER Symposium

SY 4

BRACCO Symposium

WEDNESDAY, JUNE 1, 2022

FRIDAY, JUNE 3, 2022

12:45 – 13:45

SY 2

GE Symposium

12:45 – 13:45

12:45 – 13:45

SY 3

GUERBET Symposium

13:45 – 14:30

ISWS 1SIEMENS Lecture

SY 5

GE Symposium

59This promotional symposium is organized and funded by Bayer

ESGAR 2022 – Lisbon, Portugal

Lunch
Symposium*

PP-PF-RAD-ALL-0225-1

May 2022

May 31, 2022
12:15 –13:15• Liver Lesion Stratification with MRI:
From Benign, Borderline to Malignant
Chair: Prof. Dow-Mu Koh
Speakers: Prof. Ahmed Ba’Ssalamah,Prof. Francesco DeCobelli, Dr. Jose Presa Ramos,Prof. Helena Cortez-Pinto* lunch packages will be provided after the symposium by ESGARTUESDAY, MAY 31, 2022
12:15 – 13:15 / Lunch Symposium
SY 1
BAYER: Liver lesion stratification with MRI: from benign, borderline to malignant

Auditorium I

Moderator: D.-M. Koh, Sutton/UK
12:15	Welcome
Benign and borderline lesion imaging on CE-MRI with a focus on hepatic adenoma sub-type classification
A. Ba-Ssalamah, Vienna/AT
Characterization and management of malignant liver disease
F. De Cobelli, Milan/IT
Panel Discussion
A. Ba-Ssalamah, Vienna/AT; F. De Cobelli, Milan/IT; J. Ramos Presa, Vila Real/PT; H. Cortez-Pinto, Lisbon/PT

61

GE HEALTHCARE-SPONSORED EVENTS • ESGAR 2022

Visit the GE Healthcarebooth to learn more
about our latest technology
and contrast media
products and solutions
Enhance your knowledge with three informative sessions
SYMPOSIUM:
Abdominal CT –Ways to maximize benefits

SYMPOSIUM:

Wednesday 1 June 2022

Friday 3 June 2022

Time: 12:45–13:45
Room: Auditorium 1
Lunch boxes will be provided

Time: 12:45–13:45
Room: Auditorium 1
Lunch boxes will be provided

Speakers:
Prof Andrea Laghi

Moderator:
Dr David Bowden

Prof Perry Pickhardt

Speakers:
Prof Alain LucianiSant’Andrea Hospital, Sapienza University of Rome, Italy
University of Wisconsin, USA

Deep Learning reconstruction applied
to daily liver & pancreas imaging

Addenbrooke’s Cambridge University Hospitals, UK

University Hospital Henri Mondor AP-HP, Paris, France

Dr Marc Zins

Groupe Hospitalier Paris Saint Joseph, France

WEBINAR PRE-EVENT:
AI in Radiology: which benefits for radiologists and patients?
Thursday 19 May 2022 • 13:00–14:00
Speakers: Prof Alain Luciani

University Hospital Henri Mondor AP-HP, Paris, France

Dr Marta ZerunianSant’Andrea Hospital - Sapienza University of Rome, Italy

Did you miss it? Come and speak to us on the GE Healthcare booth for access details© GE, 2022. GE and the GE Monogram are trademarks of GE.
GE Healthcare Limited, Pollards Wood, Nightingales Lane, Chalfont St Giles, Buckinghamshire, England HP8 4SP, www.gehealthcare.com
04-2022 JB01742UK/OSWEDNESDAY, JUNE 1, 2022
12:45 – 13:45 / Lunch Symposium
SY 2
GE HEALTHCARE: Abdominal CT – Ways to maximize benefits

Auditorium I

Moderators: A. Laghi, Rome/IT; P.J. Pickhardt, Madison, WI/US
12:45	Introduction
A. Laghi, Rome/IT
12:50	The value and challenges of opportunistic CT screening
P.J. Pickhardt, Madison, WI/US
13:02	Artificial Intelligence (AI) and contrast optimization in abdominal imaging
A. Laghi, Rome/IT
13:14	The added value of positive oral contrast in abdominal CT
P.J. Pickhardt, Madison, WI/US
13:26 Questions and answers

FRIDAY, JUNE 3, 2022
12:45 – 13:45 / Lunch Symposium
SY 5
GE HEALTHCARE: Deep learning reconstruction applied to daily
liver and pancreas imaging

Auditorium I

Moderator: D. Bowden, Cambridge/UK
12:45	Introduction
D. Bowden, Cambridge/UK
12:55	Will compressed sensing and deep-learning reconstruction set a new standard for pancreas imaging?
M. Zins, Paris/FR
13:15	Spectral imaging and deep-learning reconstruction: a game changer?
A. Luciani, Créteil/FR
13:35 Questions and answers

63

Lunch Symposium

ESGAR 2022

Challenge your Expertise in
Advanced Abdominal ClinicalCases - 7th Edition
Chairperson:
Valérie Vilgrain (France)

Wednesday,June 1st

12:45 - 13:45

Auditorium 6

Introduction

Challenge your expertise on advanced
clinical cases presented by:- Valérie Vilgrain (France) :Liver and pancreas- Damian Tolan (UK) :BowelsQ&A and Conclusion

ROM (P210000) - Mars 2022 - Design : floo artistic- Luis Guimarães (Portugal) :Pancreas and bowels

WEDNESDAY, JUNE 1, 2022
12:45 – 13:45 / Lunch Symposium
SY 3
GUERBET: Challenge your expertise in advanced abdominal clinical cases – 7th edition

Auditorium VI

Moderator: V. Vilgrain, Clichy/FR
12:45	Introduction
V. Vilgrain, Clichy/FR
12:50	Liver and pancreas
V. Vilgrain, Clichy/FR
13:05	Pancreas and bowels
L. Guimarães, Porto/PT
13:20	Bowels
D. Tolan, Leeds/UK
13:35 Questions and answers

65

THURSDAY, JUNE 2, 2022
12:45 – 13:45 / Lunch Symposium
SY 4
BRACCO: Back to the future: a fresh look at enhanced liver MRI

Auditorium I

Moderator: L. Martí-Bonmatí, Valencia/ES
12:45	Introduction
L. Martí-Bonmatí, Valencia/ES
12:50	Diagnosis of hepatocellular carcinoma using LI-RADS and hepatobiliary contrast agents
A. Furlan, Pittsburgh, PA/US
13:10	MRI of focal liver lesions: evidence-based comparison of hepatobiliary contrast agentsL. Grazioli, Brescia/IT
13:30 Questions and answers

67

WEDNESDAY, JUNE 1, 2022
13:45 – 14:30 / Industry Lecture
ISWS 1SIEMENS: What you should know about spectral CT and why it may change
your abdominal radiology practice
M. Lichy, Forchheim/DE; A. Ziegler, Forchheim/DE

68

Room 5AESGAR AUTUMN WORKSHOPS 2022
SEPTEMBER
ESGAR/ESDO HPB and GI Tract Neoplasms Workshop
optimising diagnosis and interactive tumour board management
September 1 – 2, 2022
Seville, Spain
Liver Imaging Workshop
September 29 – 30, 2022
Palermo, Italy
Virtual Rectal MR Imaging
a step-wise approach
September 26 & October 17, 2022
OCTOBER
Virtual CT Colonography Workshop – the essentials
October 13 – 14, 2022
NOVEMBER
Virtual ESGAR/ESUR Acute Abdomen Workshop
November 17 – 18, 2022
Virtual Liver Workshop – a case-based approach
November 24 – 25, 2022
DECEMBER
Virtual Workshop – optimising the role of CT
in abdominal imaging
December 15 – 16, 2022

www.esgar.org/workshops

69

th
It’s
happening!
30 United European

You can now Week
Gastroenterology
oﬀicially belong
to UEG.
In Vienna and Online
October 8–11, 2022

In a hybrid world,
Our myUEGas
Community
is your connection to an
engageoneinternational andmultidisciplinary digestive health community.
connected
community.
Become a myUEG Associate.

ueg.eu/week
Join our myUEG Community.

70

ueg.eu/myueg-community

NOTES

71

EXHIBITORS AND SPONSORSBAYER AG, PHARMAMEDICAL IP

Müllerstrasse 178
DE – 13353 Berlin
Phone: +49 30 468 1111
www.radiology.bayer.com

9F, Jong-ro-33-gil, Jongno-gu
KR – 03129 Seoul
Phone: +82-2-2135-9148
Fax: +82-2-2135-9149
E-Mail: contact@medicalip.com
www.medicalip.com

BRACCO
Bracco Suisse SA
Via Ponteggia 23
CH – 6814 Cadempino
E-Mail: MediaRelations.Imaging@bracco.com
www.braccoimaging.com

COLLECTIVE MINDS RADIOLOGY
Svärdvägen 5
DK – 183 22 Danderyd
Phone: +46 (0)705 218 650
E-Mail: support@cmrad.com
https://about.cmrad.com

COOK MEDICALMINT MEDICAL GMBH
Burgstrasse 61
DE – 69121 Heidelberg
Phone: +49 6221 321 80 0
E-Mail: info@mint-medical.com
www.mint-medical.com

QUIBIM S.L.
Avenida Aragon 30, 13th floor, Office I-J
ES – 46021 Valencia
Phone: +34 96 124 32 25
https://quibim.com/

O’Halloran Road
National Technology Park
IE – Limerick
Phone: +353 61 334 440
www.cookmedical.eu

SIEMENS HEALTHINEERS

GE HEALTHCARETELEMEDICINE CLINIC(TMC a Unilabs company)

Pollards WoodNightingales lane
Chalfont, St Giles
UK – HP8 4SP
www.gehealthcare.com

GUERBET
15 rue des Vanesses
Zone Paris Nord II
FR – 93420 Villepinte
Phone: 0800 15 02 58
E-Mail: contact.congress@guerbet.com
https://www.guerbet.com/

72

Henkestr. 127
DE – 91052 Erlangen
E-Mail: kontakt@siemens-healthineers.com
www.siemes-healthineers.com

Torre Mapfre, C/ Marina 16-18, 33rd Floor
ES – 08005 Barcelona
Phone: +34 93 550 0750
Fax: +34 93 550 0751
E-Mail: info@telemedicineclinic.com
www.telemedicineclinic.com

EXHIBITION AREAROOMS 5A/5C
ULTRASOUND VILLAGE

Poster Area

ESGAR

Telemedicine

Siemens

PREVIEW CENTRE

BraccoPosterTerminals

Medical IP

SCIENTIFIC OFFICE

Mint
GuerbetALL AUDITORIAGEYOUNG ESGAR

Cook

QuibimRegistration

Collective Minds

Fast Lane

Bayer

ESGAR OFFICE

73

FLOORPLAN

Auditorium VI
Ground Floor

74

Auditorium VIII

Auditorium I

Auditorium I

Room 5A

Poster Area

Preview Centre

Exhibition
Area
PosterTerminals

Auditorium II

Fast Lane
CoffeeCash Bar

Scientiﬁc Ofﬁce
Young ESGAR

Entrance
Registration

III

UltrasoundVillage
Room 5C

ESGAR
Ofﬁce

75

76

ESGAR
2023
June 13-16
Annual Meeting and Postgraduate Course

Design by www.and-beyond.design | Photo by Alberto Di Maria on Unsplash

VALEN
CIA
SPAIN

European Society of Gastrointestinal and Abdominal Radiology | www.esgar.org

www.esgar.org